id	label	x	y	cluster	weight<Links>	weight<Total link strength>	weight<Occurrences>	score<Avg. pub. year>
1	3r tau	-0.3882	0.4599	3	223	366	22	2008.1818
2	3xtg	-0.3863	-0.3828	1	190	253	20	2012.75
3	3xtg ad	-0.3648	-0.3976	1	485	999	89	2011.3371
4	3xtg ad mouse	-0.3762	-0.4143	1	614	1453	137	2011.6934
5	3xtg ad mouse model	-0.3816	-0.4312	1	149	200	22	2012.2727
6	3xtg mouse	-0.3869	-0.3776	1	190	263	22	2012.4545
7	3xtgad	-0.3384	-0.4329	1	131	208	19	2011.5263
8	3xtgad mouse	-0.3407	-0.433	1	229	380	36	2011.5833
9	4r tau	-0.2299	0.5363	3	258	459	28	2007.1786
10	a68	-0.8401	0.5106	4	174	284	19	1991.7368
11	aberrant accumulation	-0.6376	-0.0818	1	119	134	10	2010
12	aberrant phosphorylation	-0.8765	-0.0679	1	190	292	19	2005.4737
13	aberrant tau phosphorylation	-0.6678	-0.2444	1	124	150	13	2006.9231
14	abeta clearance	-0.1161	-0.3591	1	262	362	34	2012.2059
15	abeta degradation	-0.2775	-0.4199	1	164	194	14	2009.7143
16	abeta fibril	-0.1323	-0.2366	1	148	184	16	2009.25
17	abeta formation	-0.4499	-0.3543	1	146	175	15	2008.5333
18	abeta generation	-0.3564	-0.3079	1	266	386	33	2010.697
19	abeta immunotherapy	0.1111	-0.3726	1	212	316	23	2009.7826
20	abeta metabolism	0.4111	-0.4599	1	188	256	19	2010.3158
21	abeta precursor protein	-0.43	-0.1763	1	122	145	13	2010.1538
22	abeta ratio	1.4563	0.0657	2	160	281	12	2010.4167
23	abeta toxicity	-0.6343	-0.2661	1	312	473	41	2010.7561
24	abeta treatment	-0.7467	-0.2715	1	150	196	13	2011.1538
25	abeta1	0.9968	-0.2873	2	941	3050	164	2011.8171
26	abeta40	0.7515	-0.3597	2	509	1027	59	2010.339
27	abeta42	1.1057	-0.2218	2	1279	7326	404	2010.6337
28	abeta42 concentration	1.301	-0.1029	2	250	467	22	2010.5455
29	abeta42 level	1.2041	-0.1649	2	398	821	40	2011.825
30	abeta42 ratio	1.4238	-0.19	2	191	326	14	2011.5714
31	abnormal aggregation	-0.7312	0.1836	4	164	223	14	2008.8571
32	abnormal filament	-0.4752	0.5333	3	170	284	20	1995.9
33	abnormal hyperphosphorylation	-1.0546	-0.1043	4	541	1650	97	2006.7835
34	abnormal level	1.3757	0.0336	2	174	272	14	2011.5714
35	abnormal neurite	-0.4459	0.4625	3	152	242	19	1996.3684
36	abnormal phosphorylation	-1.0117	0.2485	4	640	1558	109	2001.4954
37	abnormal tau	-0.5557	0.4903	3	497	1024	64	2003.4375
38	abnormal tau phosphorylation	-0.9439	-0.0652	4	277	450	35	2006.2857
39	abnormal tau protein	-0.172	0.5567	3	230	381	29	1997.5862
40	absorption	-0.7101	0.4071	4	157	213	17	2003
41	abundant neurofibrillary tangle	-0.1324	0.5069	3	116	174	12	2000.1667
42	acad	-0.6435	0.253	4	124	154	10	2001.5
43	accuracy	1.2706	-0.2361	2	677	2759	127	2010.7244
44	accurate diagnosis	0.7177	-0.0259	2	231	374	24	2010.125
45	ace	0.2609	-0.2784	1	133	197	11	2008.4545
46	acetylation	-0.6234	-0.1879	1	186	239	18	2010.5556
47	acetylcholine	-0.1955	-0.3523	1	403	724	55	2006.8909
48	acetylcholinesterase	-0.1613	-0.3841	1	420	754	53	2008.4151
49	acetylcholinesterase inhibitor	-0.0359	-0.4043	1	329	563	45	2007.8222
50	ach	-0.2006	-0.3644	1	205	299	21	2009.1429
51	ache	-0.0884	-0.4112	1	374	664	44	2008.0909
52	achei	-0.0193	-0.4099	1	141	187	12	2010
53	acid form	1.0078	-0.3794	2	216	384	20	2006.25
54	acid residue	-0.992	0.2792	4	222	351	24	2002.4167
55	actin	-0.5345	0.0927	3	244	343	26	2004.3462
56	actin cytoskeleton	-0.5618	0.0652	1	94	124	11	2009.6364
57	activation	-0.6199	-0.3411	1	1570	8560	647	2009.1731
58	activator	-0.8594	-0.3144	1	538	1226	77	2006.6494
59	active form	-0.7587	-0.1061	1	234	342	22	2006.8182
60	active immunization	0.0093	-0.3561	1	175	312	24	2010.25
61	ad biomarker	1.1041	-0.1422	2	635	1859	100	2012.02
62	ad brain section	-0.1977	0.1873	4	149	247	19	2009.2105
63	ad brain tissue	-0.7324	0.2206	4	212	284	21	2010.0952
64	ad cortex	-0.6144	0.4345	4	106	131	11	2001.4545
65	ad dementia	1.1761	-0.164	2	438	1064	54	2012.3704
66	ad diagnosis	1.1903	-0.2468	2	501	1331	71	2010.4507
67	ad group	1.2266	-0.1418	2	620	1983	101	2007.4554
68	ad hippocampus	-0.5223	0.3461	3	226	344	25	2002.04
69	ad model	-0.4541	-0.3687	1	552	978	86	2012.4535
70	ad mouse	-0.3918	-0.4048	1	412	763	65	2012.2769
71	ad mouse model	-0.4362	-0.4186	1	467	823	71	2012.5352
72	ad neurodegeneration	-0.7253	-0.2946	1	107	137	13	2008.8462
73	ad neuron	-0.8115	-0.1213	1	234	302	23	2007.4783
74	ad p	-1.1474	0.2302	4	172	419	21	2001.0476
75	ad risk	0.9102	0.4288	2	366	785	51	2010.9608
76	ad sample	-0.6082	0.5015	4	191	242	15	2002.6667
77	ad subject	0.7704	-0.1319	2	688	1580	93	2010.4516
78	ad tau	-0.6482	0.6234	4	132	172	10	1998.2
79	ad therapeutic	-0.2237	-0.3531	1	175	206	17	2011.4118
80	ad therapy	-0.2394	-0.3826	1	286	409	40	2011.025
81	ad tissue	-0.6351	0.0796	4	127	149	14	2003.1429
82	ad transgenic mouse	-0.4238	-0.3908	1	209	290	21	2011.7619
83	ad transgenic mouse model	-0.5421	-0.3856	1	122	142	12	2011.6667
84	adas cog	0.859	-0.4888	2	222	434	21	2010.5714
85	adjustment	1.3095	0.1424	2	269	445	22	2010.5
86	administration	-0.3987	-0.4849	1	906	2462	187	2010.5775
87	adni	1.3694	0.1435	2	445	1709	70	2012.6571
88	adni cohort	1.3723	0.0526	2	173	272	11	2012.1818
89	adult brain	-0.9461	0.0777	4	317	537	36	2003.6389
90	adult human brain	-0.8334	0.4464	4	215	362	22	2004.3182
91	adult neurogenesis	-0.5388	-0.3344	1	105	137	14	2011.1429
92	advent	0.4383	-0.1159	2	215	271	18	2011.5
93	adverse effect	-0.2204	-0.4165	1	357	516	38	2010.1316
94	adverse event	0.2925	-0.4882	1	198	400	22	2009.4545
95	affected neuron	-1.0254	0.2243	4	303	579	36	2001.6667
96	affinity	-0.8456	0.2283	4	641	1503	99	2005.4545
97	agd	0.0143	0.5736	3	221	397	25	2006.16
98	age group	0.2631	0.0021	2	120	167	12	2008.5
99	age range	0.9456	0.1713	2	167	211	12	2006.4167
100	aged 3xtg ad mouse	-0.3386	-0.3735	1	126	154	14	2011.5714
101	aged control	-0.4317	0.4064	3	174	220	18	2000.6667
102	ages	-0.5127	-0.2196	1	189	320	27	2005.037
103	aggregated amyloid beta	-0.4314	-0.2159	1	101	108	11	2011.7273
104	aggregated protein	-0.6081	0.0166	4	194	250	22	2011.5
105	aggregated tau	-0.6724	0.1802	4	220	300	25	2011.32
106	aggregated tau protein	-0.5706	0.2543	4	119	138	14	2002.7857
107	aggregation process	-0.8708	0.1785	4	161	215	18	2009.5
108	agitation	0.3361	-0.0793	3	156	202	13	2008.8462
109	agonist	-0.2534	-0.396	1	426	781	58	2007.8276
110	aid	1.0422	-0.2877	2	302	577	33	2006.697
111	akt	-0.7036	-0.5062	1	420	1020	63	2011.2381
112	algorithm	1.0495	-0.0035	2	373	660	32	2010.4688
113	alkaline phosphatase	-0.9067	0.4597	4	306	636	40	1996.45
114	alkaline phosphatase treatment	-0.9178	0.4978	4	129	206	13	1993.2308
115	allele	0.8092	0.4158	2	905	3019	203	2005.5271
116	allele frequency	0.8164	0.5051	2	209	382	24	2004.4167
117	alpha secretase	-0.2458	-0.3529	1	174	243	17	2007.9412
118	alpha syn	0.3937	0.1701	3	204	273	17	2012.4706
119	alpha synuclein pathology	0.2709	0.4149	3	183	244	19	2010.6842
120	alpha synucleinopathy	-0.0812	0.4472	3	237	344	23	2008.3478
121	alpha7 nicotinic acetylcholine receptor	-0.4042	-0.3913	1	118	158	11	2011.7273
122	als	0.1998	0.4839	3	148	215	16	2007.5
123	alternative approach	-0.1479	-0.3912	1	117	131	12	2011.75
124	alternative splicing	-0.6652	0.2488	4	305	541	37	2008.4865
125	aluminum	-0.4777	0.1234	1	238	363	34	2000.8824
126	alz	-0.7666	0.519	4	367	845	56	1995.7321
127	alz50	-0.6657	0.384	4	145	208	15	2000.9333
128	alzheimer brain	-0.7486	0.479	4	500	1204	88	1997.5227
129	alzheimer brain tissue	-0.968	0.2719	4	140	191	11	1998.8182
130	alzheimer case	-0.5435	0.4521	3	119	154	11	2000.0909
131	alzheimer dementia	0.8086	0.0583	2	268	422	28	2007.4286
132	alzheimer disease biomarker	1.414	0.066	2	174	297	15	2012.5333
133	alzheimer disease brain	-0.8111	0.3001	4	390	773	50	2001.86
134	alzheimer disease pathology	0.5649	0.0376	2	290	406	28	2009.6786
135	alzheimer neurofibrillary degeneration	-1.1343	0.2039	4	165	312	17	2002.1765
136	alzheimer neurofibrillary tangle	-0.7466	0.5209	4	332	723	45	1993
137	alzheimer tau	-1.1506	0.2608	4	115	189	10	1995.8
138	alzheimer type dementia	0.1113	0.3497	3	263	363	28	1999.8571
139	alzheimer type pathology	0.2197	0.4471	3	317	502	39	2005.3333
140	amci	1.3549	0.0253	2	226	469	21	2011.5238
141	amelioration	-0.4023	-0.4204	1	229	324	26	2011.6154
142	amino acid sequence	-0.8505	0.4639	4	189	285	22	2000.8182
143	amino terminus	-0.8876	0.45	4	186	255	17	1997.0588
144	amino2 naphthylethylidene	0.9412	0.0268	2	124	213	10	2009.6
145	amnestic mci	1.1484	-0.0462	2	198	344	16	2011
146	amnestic mild cognitive impairment	1.2333	-0.0312	2	400	942	46	2011.3261
147	ampk	-0.6071	-0.5266	1	139	222	14	2012.5
148	amygdala	-0.0276	0.3823	3	613	1297	97	2003.5361
149	amyloid beta precursor protein	-0.3965	-0.2796	1	180	227	23	2010.1304
150	amyloid beta production	-0.5046	-0.483	1	203	263	22	2010.8182
151	amyloid beta42	1.2381	-0.2471	2	311	535	30	2012.4333
152	amyloid core	-0.3704	0.4345	3	220	309	21	1997.7619
153	amyloid imaging	1.0128	0.0049	2	416	886	45	2011.3556
154	amyloid load	0.927	0.05	2	437	784	47	2009.4468
155	amyloid pet	1.003	-0.0175	2	220	431	16	2013.875
156	amyloid plaque formation	-0.5189	-0.1037	1	140	172	18	2008.0556
157	amyloid precursor	-0.5792	-0.2018	1	99	104	11	2005.6364
158	amyloid precursor protein gene	0.1309	0.3353	3	156	195	18	2002.2222
159	amyloid substance	-0.1407	0.3759	3	108	156	14	1993.9286
160	amyloidogenic pathway	-0.4211	-0.246	1	165	202	14	2010.0714
161	amyloidogenic processing	-0.4122	-0.2932	1	199	257	21	2010.6667
162	amyloidogenic protein	-0.6731	0.1539	4	202	262	23	2008.6957
163	amyotrophic lateral sclerosis	0.0321	0.3848	3	631	1330	97	2008.3402
164	an1792	0.09	-0.3726	1	102	164	11	2011.5455
165	analyte	1.2066	-0.2682	2	326	725	31	2011.9677
166	anesthesia	-0.2238	-0.5225	1	253	419	32	2011.3438
167	anesthetic	-0.2251	-0.5212	1	115	186	16	2012.375
168	ant	-0.6921	0.3788	4	117	151	10	2005.8
169	antagonist	-0.2914	-0.3526	1	357	549	44	2010.5909
170	anti	-0.3625	0.3228	3	976	2808	198	2003.1465
171	anti abeta antibody	0.0577	-0.3606	1	206	324	22	2010.1364
172	anti inflammatory	-0.4227	-0.4555	1	110	141	16	2011.0625
173	anti inflammatory agent	0.0004	-0.4264	1	115	137	12	2005.75
174	anti inflammatory drug	-0.1339	-0.3987	1	170	227	21	2005.4762
175	anti inflammatory effect	-0.2325	-0.4296	1	147	176	12	2011.8333
176	anti tau	-0.1971	0.4361	3	247	389	28	1998.2143
177	anti tau antibody	-0.5016	0.4846	3	186	260	15	2000.8
178	antibody	-0.5071	0.3795	3	1586	10338	716	2001.5698
179	antioxidant	-0.1904	-0.4133	1	405	651	56	2007.3929
180	antioxidant activity	-0.4821	-0.459	1	104	125	12	2010.4167
181	antisera	-0.5518	0.5485	3	317	635	43	1992.7209
182	antiserum	-0.5791	0.5589	3	284	563	40	1992.8
183	apathy	0.4239	0.2062	3	196	255	12	2009.1667
184	aphasia	0.5302	0.4837	3	271	616	36	2009.0833
185	apoe	0.8869	0.3525	2	1180	5194	324	2007.2407
186	apoe allele	0.84	0.3566	2	126	171	12	2000.5833
187	apoe epsilon	0.8638	0.3489	2	277	450	26	2002.8077
188	apoe epsilon4	1.1105	0.328	2	270	477	26	2008.5
189	apoe epsilon4 allele	0.9699	0.3096	2	330	603	29	2008.4828
190	apoe epsilon4 carrier	1.1279	0.3053	2	215	385	20	2010.6
191	apoe gene	0.8026	0.4359	2	97	133	11	2010.0909
192	apoe genotype	1.189	0.2572	2	587	1650	88	2008.5568
193	apoe4 allele	0.8451	0.4169	2	171	238	14	2008.9286
194	apolipoprotein e	0.8182	0.3493	2	941	2868	187	2005.1016
195	apolipoprotein e epsilon	0.7431	0.4374	2	114	157	11	1997.9091
196	apolipoprotein e gene	0.8669	0.3752	2	155	223	14	2007
197	apolipoprotein e genotype	0.7478	0.4401	2	208	318	22	2000.4545
198	apoptosis	-0.6736	-0.2921	1	957	2790	217	2007.9032
199	apoptotic cell death	-0.8436	-0.2506	1	200	317	22	2007.4545
200	app expression	-0.4024	-0.2816	1	100	120	13	2007.9231
201	app gene	-0.0856	0.1536	3	128	142	14	2004.2857
202	app mouse	-0.4264	-0.355	1	141	168	16	2009.0625
203	app processing	-0.4472	-0.2867	1	446	794	67	2009.209
204	app ps1	-0.4278	-0.4073	1	230	312	25	2012.96
205	app ps1 mouse	-0.4495	-0.4379	1	272	457	42	2012.881
206	app ps1 transgenic mouse	-0.4985	-0.4995	1	215	333	23	2013.3478
207	appsw	-0.408	-0.3459	1	101	115	12	2008.5
208	appswe	-0.3823	-0.3939	1	249	347	21	2012.0952
209	apraxia	0.3814	0.4586	3	222	367	22	2006.5
210	arachidonic acid	-0.7798	0.0964	4	94	122	10	2005.1
211	areas covered	-0.0725	-0.3044	1	113	141	13	2013.3077
212	argyrophilic grain	0.0245	0.5521	3	210	392	25	2004.16
213	argyrophilic grain disease	0.0293	0.5678	3	443	999	58	2006.2586
214	art	0.8525	-0.3331	2	173	250	14	2009.1429
215	asp	-0.7321	0.2074	4	136	177	14	2005.9286
216	assembly	-0.8986	0.2187	4	873	2923	205	2004.8195
217	assessment	0.7984	-0.0657	2	1054	3735	213	2009.2958
218	association analysis	0.8436	0.5094	2	153	266	16	2009.3125
219	association study	0.876	0.4751	2	217	431	28	2007.6429
220	astrocytic plaque	0.0385	0.5468	3	174	301	14	2003.4286
221	astrogliosis	-0.3676	-0.3201	1	286	399	33	2008.6061
222	at100	-0.8013	0.1576	4	161	230	13	2006.4615
223	at180	-0.4116	0.382	3	165	234	13	2004.6923
224	at8	-0.4609	0.3347	3	585	1286	80	2005.5
225	at8 antibody	-0.2889	0.4365	3	101	132	10	2002.8
226	atomic force microscopy	-0.774	0.2255	4	86	111	10	2006.5
227	atp	-0.7639	-0.0322	4	291	458	41	2006.2927
228	atrophy	0.7136	0.3007	3	956	3327	187	2009.3957
229	atrophy rate	1.4354	0.1122	2	214	492	21	2011.4286
230	attenuation	-0.5703	-0.4268	1	347	567	42	2011.119
231	auc	1.4615	-0.2639	2	270	595	25	2012.6
232	autophagosome	-0.5654	-0.0458	1	100	128	11	2012.3636
233	autophagy	-0.5382	-0.0722	1	472	858	80	2011.3625
234	autopsy	0.5193	0.3428	3	854	2288	137	2006.4745
235	autopsy brain	0.2235	0.3821	3	134	175	15	2002
236	autopsy case	0.1458	0.4615	3	319	573	41	2004.9268
237	autopsy series	0.4555	0.4144	3	175	231	15	2006.2
238	autoradiography	-0.1095	0.0768	4	146	238	16	2011.5625
239	average	0.7436	0.1344	2	298	447	25	2007.2
240	axon	-0.5229	0.2736	3	770	1904	149	2004.302
241	axonal degeneration	0.8279	-0.2896	2	300	515	33	2008.1818
242	axonal microtubule	-0.8754	0.0644	4	190	255	18	2004.6111
243	axonal transport	-0.7238	-0.0595	1	535	1086	95	2008.4842
244	bace	-0.2243	-0.324	1	260	404	30	2010.4
245	bace1 activity	0.8337	-0.5015	2	147	238	15	2011.1333
246	background aims	1.1208	0.2216	2	227	364	23	2010.5217
247	band	-0.4587	0.5631	3	561	1203	75	1999.8267
248	bapineuzumab	0.1389	-0.3983	1	130	207	13	2012.6154
249	basal ganglia	0.1603	0.4801	3	171	214	15	2005.0667
250	basal ganglium	0.1438	0.5113	3	233	344	22	2006.2273
251	basal nucleus	-0.1302	0.414	3	109	144	11	2001.8182
252	baseline	1.3464	-0.1332	2	716	3307	149	2010.4631
253	baseline csf	1.5091	0.0856	2	159	270	11	2010.8182
254	basic research	-0.0591	-0.3079	1	86	102	10	2010.7
255	battery	0.5777	-0.2198	2	495	872	44	2009.9091
256	bax	-0.7518	-0.4079	1	168	279	18	2010.3889
257	bcl	-0.7539	-0.401	1	236	407	27	2009.2593
258	bdnf	-0.4932	-0.3564	1	366	569	42	2011.2857
259	behavioral deficit	-0.4123	-0.367	1	411	640	54	2010.7778
260	behavioral impairment	-0.4355	-0.4007	1	141	178	19	2010.1579
261	behavioral performance	-0.3053	-0.4859	1	132	162	13	2011.3846
262	behavioral test	-0.3744	-0.4614	1	198	288	22	2013.4091
263	behavioral variant frontotemporal dementia	0.4725	0.4406	3	145	213	13	2013.1538
264	behavioural	0.3234	-0.1538	3	215	272	15	2009.3333
265	beneficial effect	-0.335	-0.4607	1	544	965	85	2010.2235
266	beta a4	-0.1371	0.3897	3	128	170	15	1994.1333
267	beta amyloid aggregation	0.1724	-0.4612	1	106	124	10	2012.3
268	beta amyloid formation	0.0251	-0.3825	1	73	91	10	2007.9
269	beta amyloid production	-0.4657	-0.2823	1	190	233	19	2008.9474
270	beta app	-0.2456	0.1787	3	119	148	16	1996.5625
271	beta catenin	-0.7532	-0.3814	1	167	259	20	2009
272	beta deposit	-0.1497	0.3324	3	226	331	34	2004.2353
273	beta protein	-0.0756	-0.0789	1	934	2058	179	2004.933
274	beta secretase inhibitor	-0.0281	-0.3743	1	142	184	12	2008.8333
275	beta sheet	-0.8572	0.2624	4	173	251	19	2006.3684
276	beta sheet structure	-0.8873	0.2863	4	142	218	14	2006.4286
277	beta site amyloid precursor protein	0.0288	-0.591	1	149	211	13	2011.9231
278	beta structure	-0.9339	0.2697	4	154	329	21	2005.8095
279	bielschowsky	-0.1509	0.4561	3	155	218	16	1997.375
280	bin1	0.7933	0.4322	2	106	138	10	2013.8
281	bind	-0.7458	0.2419	4	930	2576	181	2005.2762
282	bind microtubule	-1.054	0.008	4	105	148	10	2003
283	binding affinity	-0.305	0.1565	4	231	349	26	2010.2692
284	binding site	-0.9353	0.1457	4	499	921	63	2005.3492
285	biochemical marker	0.9365	-0.2745	2	457	1043	62	2002.9839
286	biochemical property	-0.819	0.4723	4	178	237	13	2001.3846
287	biological activity	-0.3826	-0.1886	1	344	530	34	2008.2941
288	biological function	-0.8203	0.0152	4	227	322	23	2008.2174
289	biological marker	0.8949	-0.2915	2	550	1499	96	2005.5
290	biomarker	1.117	-0.197	2	1428	16355	894	2011.1633
291	biomarker candidate	1.1841	-0.376	2	224	413	17	2008.8235
292	biomarker change	1.2041	-0.0477	2	269	550	24	2012.6667
293	biomarker level	1.2931	0.0833	2	397	871	39	2012.3846
294	biomarker profile	1.3863	0.0713	2	267	563	27	2011.7407
295	biomarker study	1.0996	-0.1053	2	234	391	22	2012.4545
296	biopsy	-0.0004	0.1858	3	346	608	37	2000.7838
297	blockade	-0.3058	-0.3081	1	217	273	22	2009.5
298	blood	0.5955	-0.3287	2	676	1506	102	2010.2647
299	blood pressure	0.4641	-0.3472	2	162	209	14	2013.3571
300	blood vessel	-0.2026	0.3789	3	267	384	33	2004.697
301	body mass index	1.3985	0.0924	2	154	260	13	2011.9231
302	body weight	-0.3824	-0.5307	1	152	200	14	2012
303	bovine brain	-0.9008	0.5016	4	138	212	12	1994.4167
304	bovine tau	-0.9205	0.4671	4	187	335	17	1995.6471
305	box	1.2246	0.0756	2	319	574	26	2011.3846
306	braak staging	0.267	0.3169	3	196	265	20	2007.75
307	brain atrophy	1.0359	0.111	2	578	1527	84	2010.7262
308	brain change	1.0512	0.0276	2	280	465	27	2011.4815
309	brain development	-0.7868	-0.1241	1	160	215	18	2006.5
310	brain extract	-0.6965	0.0893	4	320	440	30	2005.4667
311	brain homogenate	-0.6701	0.4753	4	441	842	54	2001.8704
312	brain imaging	0.8957	-0.156	2	402	718	36	2010.2778
313	brain insulin	-0.4488	-0.5751	1	136	249	16	2012.625
314	brain insulin resistance	-0.4174	-0.5757	1	172	256	17	2012.5294
315	brain metabolism	0.5494	-0.3265	2	180	223	16	2011.0625
316	brain section	-0.4891	0.3921	4	366	615	44	2005.1364
317	brain slice	-0.9238	-0.2792	1	332	580	36	2008.5278
318	brain stem	-0.0091	0.442	3	164	206	15	2001.5333
319	brain structure	0.8312	0.015	2	356	561	30	2009.8667
320	brain volume	1.2593	0.0928	2	246	464	20	2011.4
321	brainstem	0.0616	0.4456	3	420	759	53	2005.9434
322	brainstem nuclei	-0.001	0.3892	3	141	173	13	2009.1538
323	breakdown	-0.882	-0.0304	4	296	481	34	2005.2353
324	brodmann area	0.0807	0.4322	3	152	193	14	2002.7857
325	buche	-0.095	-0.4222	1	160	250	15	2008.5333
326	buildup	-0.5092	-0.1218	1	158	192	19	2011.1579
327	bundle	-0.5715	0.4207	3	365	674	45	2000.0889
328	butyrylcholinesterase	-0.1231	-0.4221	1	260	428	29	2010.0345
329	bvftd	0.6664	0.4137	3	189	314	15	2013.1333
330	c elegan	-0.5724	-0.0734	1	95	112	11	2009.1818
331	c jun n terminal kinase	-0.7624	-0.345	1	308	559	31	2008.3226
332	c pib	0.9742	0.0375	2	157	239	10	2012.3
333	c terminal domain	-0.9662	0.2422	4	159	216	13	2003.3077
334	c terminal fragment	-0.4696	0.0072	1	276	431	35	2007.5143
335	c terminal truncation	-0.8809	0.225	4	124	175	10	2006.7
336	c termini	-0.8084	0.2733	4	187	256	18	2004.7778
337	c terminus	-0.846	0.2899	4	353	673	49	2005
338	c57bl	-0.3924	-0.5226	1	112	133	12	2011.9167
339	c9orf72	0.4721	0.4949	3	131	198	10	2013.3
340	ca1	-0.353	0.208	3	451	813	64	2007.125
341	ca1 neuron	-0.4282	-0.1021	1	158	204	15	2009.5333
342	ca2	-0.3278	0.2973	3	283	410	26	2003.7308
343	ca3	-0.4103	0.0161	1	142	193	16	2006.875
344	ca4	-0.3373	0.2881	3	155	218	14	2005.5
345	calcineurin	-0.9917	-0.0967	4	239	397	32	2005.2812
346	calcium homeostasis	-0.4761	-0.2401	1	224	312	33	2008.5455
347	calpain	-0.8034	-0.2946	1	417	885	63	2008.5079
348	calpain activation	-0.7847	-0.2484	1	184	275	17	2008.8235
349	camkii	-0.9323	-0.2544	1	162	245	12	2009.5833
350	candidate biomarker	1.0089	-0.3289	2	260	451	22	2011.8636
351	candidate gene	0.7271	0.4841	2	207	333	22	2007.4091
352	carbon	0.6835	0.1214	2	189	260	14	2006.5714
353	cardinal feature	-0.2823	-0.0577	1	142	160	15	2009.6
354	caregiver	0.3563	-0.3561	1	170	223	14	2009.1429
355	carrier	0.9597	0.2357	2	743	2369	126	2010.7302
356	case control study	0.8762	0.4424	2	331	685	40	2009.775
357	case report	0.3301	0.3621	3	186	254	17	2007.4706
358	casein kinase	-0.7462	0.2745	4	195	291	18	2004.2778
359	caspase	-0.6843	-0.2285	1	786	2140	146	2008.9863
360	caspase activation	-0.7145	-0.1898	1	117	166	16	2008.5
361	caspase cleavage	-0.823	-0.0029	4	143	212	16	2008.4375
362	catalytic subunit	-0.9694	-0.2154	1	267	503	32	2007.5625
363	caudate	0.6019	0.3912	3	169	207	12	2007.5833
364	caudate nucleus	0.1297	0.4874	3	150	189	12	2004.1667
365	causative gene	0.1047	0.403	3	81	93	11	2003.5455
366	cbd	0.0581	0.5634	3	598	1519	81	2005.6296
367	cbs	0.4859	0.4562	3	112	217	11	2012.7273
368	cdc2	-1.0966	0.1803	4	227	392	22	1999.0455
369	cdk	-0.8891	-0.3078	1	172	261	15	2004.2667
370	cdk5	-0.9157	-0.2524	1	548	1413	89	2008.1348
371	cdna	-0.8746	0.4103	4	176	250	23	1996.3913
372	cdr	1.2636	0.0397	2	331	687	30	2008.5
373	cell biology	-0.7161	0.0183	4	72	79	13	2005.5385
374	cell body	-0.3466	0.4077	3	417	813	60	2001.7833
375	cell culture	-0.6335	-0.1616	1	451	697	52	2008.9423
376	cell cycle	-0.7407	-0.1123	1	357	644	63	2006
377	cell cycle progression	-0.6517	-0.0343	1	127	162	11	2006.4545
378	cell cycle re entry	-0.5741	-0.236	1	93	123	16	2008.8125
379	cell cycle regulation	-0.9521	-0.0374	4	90	124	12	2006
380	cell line	-0.8035	-0.1785	1	530	1018	75	2006.32
381	cell model	-0.7805	-0.0814	1	416	708	55	2008.4727
382	cell proliferation	-0.5853	-0.2647	1	127	155	13	2007.5385
383	cell surface	-0.5725	0.0842	1	144	173	14	2007.6429
384	cell survival	-0.7074	-0.2835	1	318	458	38	2008.5263
385	cell viability	-0.8379	-0.2673	1	237	398	26	2011.1538
386	cells	-0.6222	-0.0107	1	156	179	12	2004.1667
387	cellular localization	-0.4653	0.0714	1	94	108	10	2003.5
388	cellular model	-0.7228	-0.1769	1	336	505	41	2008.4878
389	cellular response	-0.6755	-0.1787	1	154	195	14	2007.7143
390	center	0.9459	-0.0689	2	784	2091	113	2008.9027
391	cerad	0.65	0.2626	3	208	330	19	2006.2632
392	cerad criterium	0.1752	0.4093	3	133	178	11	2000.3636
393	cerebellar cortex	-0.0223	0.4553	3	140	166	15	2000.0667
394	cerebral atrophy	0.9242	0.2311	2	242	358	17	2008.0588
395	cerebral blood flow	0.558	-0.2592	2	293	488	33	2008.4848
396	cerebral blood vessel	-0.3943	0.1537	4	83	91	10	2004.1
397	cerebral glucose metabolism	0.9074	0.011	2	294	508	30	2008.5
398	cerebral ischemia	-0.2895	-0.3726	1	142	194	19	2008.3158
399	cerebral spinal fluid	1.2272	0.1396	2	264	383	20	2010.85
400	cerebrospinal fluid	1.1577	-0.2184	2	1503	19890	1088	2009.5404
401	cerebrospinal fluid amyloid beta	1.4164	-0.0217	2	161	225	13	2010.7692
402	cerebrospinal fluid beta	1.0832	-0.0775	2	184	267	15	2009.1333
403	cerebrospinal fluid biomarker	1.271	-0.0722	2	706	2982	157	2011.7261
404	cerebrospinal fluid level	1.1301	-0.1791	2	480	1161	65	2009.2923
405	cerebrospinal fluid marker	1.1714	0.0133	2	330	668	33	2009.9697
406	cerebrospinal fluid sample	1.0766	-0.1997	2	156	222	13	2009.6923
407	cerebrospinal fluid tau	1.2545	-0.0118	2	365	744	41	2005.878
408	cerebrovascular disease	0.6375	-0.1094	2	281	473	39	2006.6154
409	cerebrum	0.1443	0.4801	3	197	261	16	2002.4375
410	certainty	1.0428	-0.236	2	171	258	13	2008.2308
411	chaperone	-0.7005	-0.0169	4	230	357	32	2010.25
412	characteristic curve	1.4139	-0.1036	2	219	388	12	2012.5833
413	characteristic lesion	-0.1957	0.4655	3	166	195	13	2000.5385
414	chat	-0.2536	-0.257	1	148	192	17	2009.9412
415	chem	-0.7524	0.1056	4	187	270	17	2000.7647
416	cholinergic neurotransmission	-0.1824	-0.3557	1	110	132	14	2006.2143
417	cholinergic system	-0.1771	-0.3399	1	189	241	22	2008.3182
418	cholinesterase	-0.0097	-0.4046	1	211	292	21	2007.4286
419	cholinesterase inhibitor	0.0386	-0.3852	1	385	719	53	2008.5283
420	chromosome	-0.0063	0.4768	3	990	3245	216	2004.4213
421	chronic treatment	-0.4223	-0.4911	1	144	179	15	2009.7333
422	circular dichroism	-0.8951	0.2918	4	162	308	21	2006.4286
423	cjd	0.4796	0.3076	3	275	492	30	2008.0667
424	classification	0.8597	0.2498	2	630	1524	80	2008.4125
425	cleavage	-0.6991	-0.2117	1	825	2093	147	2008.5918
426	clinic	0.8829	-0.1245	2	482	968	51	2008.7843
427	clinical	0.7407	0.3013	3	344	576	30	2008.6
428	clinical application	0.1846	-0.36	1	199	274	22	2009.9091
429	clinical assessment	0.9639	0.022	2	301	505	21	2011.8571
430	clinical benefit	0.2077	-0.4211	1	182	252	15	2012.2
431	clinical characteristic	0.4243	0.409	3	154	189	13	2008.0769
432	clinical course	0.3843	0.0269	3	248	296	18	2010.6667
433	clinical criterium	0.9755	-0.0863	2	323	581	32	2009.625
434	clinical data	0.8181	-0.0824	2	351	612	29	2009.7931
435	clinical dementia	0.6623	0.192	2	313	520	36	2007.0833
436	clinical dementia rating	1.2057	0.0609	2	324	622	31	2008.1935
437	clinical diagnosis	0.9143	-0.0285	2	969	3710	201	2008.2239
438	clinical examination	1.0306	-0.3177	2	152	240	12	2005.5833
439	clinical feature	0.4518	0.3848	3	512	1032	67	2008.1343
440	clinical group	1.4523	0.0995	2	166	300	13	2011.3846
441	clinical history	0.2655	0.3742	3	144	160	10	2005.2
442	clinical measure	1.3874	0.1173	2	183	318	15	2008.8
443	clinical onset	0.6488	-0.0164	2	219	287	17	2011
444	clinical outcome	0.3457	-0.4127	1	232	357	21	2011.1905
445	clinical phenotype	0.4084	0.4267	3	446	797	49	2009.5714
446	clinical practice	0.8933	-0.2377	2	485	1160	63	2010.0159
447	clinical presentation	0.4864	0.3962	3	324	553	36	2009.0833
448	clinical progression	0.8542	-0.4342	2	266	402	26	2009.8462
449	clinical research	0.0948	-0.4283	1	116	144	12	2010.8333
450	clinical routine	1.3505	-0.318	2	152	242	11	2010.4545
451	clinical setting	1.3478	-0.2618	2	269	461	23	2011.3043
452	clinical sign	0.3894	0.1098	3	223	299	23	2006.6957
453	clinical stage	1.0258	-0.1566	2	315	552	31	2008.0645
454	clinical syndrome	0.4825	0.4456	3	277	520	32	2007.2188
455	clinical trial	0.2497	-0.3741	1	1155	4606	321	2010.7819
456	clinical use	0.2158	-0.398	1	251	348	22	2009.7273
457	clinical utility	1.1559	-0.3502	2	189	284	15	2010.5333
458	clinically	0.9255	-0.1864	2	225	302	16	2010.5
459	clinicaltrial	0.6529	-0.5293	2	169	327	14	2013.4286
460	clinician	0.7891	-0.1081	2	237	396	25	2007.92
461	clinicopathological study	0.5512	0.2851	3	188	233	15	2005.8
462	clone	-0.8009	0.4406	4	143	182	14	1999.5714
463	clu	0.9932	0.3396	2	170	364	13	2013
464	cluster analysis	1.0847	0.146	2	171	235	13	2010.3846
465	co expression	-0.6883	-0.0836	1	139	173	13	2008.0769
466	co immunoprecipitation	-0.7521	0.1536	4	133	154	10	2010.9
467	co localization	-0.4929	0.179	3	353	536	42	2007.5238
468	co localize	-0.6353	0.1326	4	153	181	14	2007.3571
469	co occurrence	0.3318	0.414	3	207	273	20	2010.35
470	codon	0.2724	0.5236	3	233	358	26	2006
471	coefficient	1.2745	-0.2859	2	311	697	37	2011
472	coexistence	0.1314	0.4459	3	196	246	18	2007
473	cofactor	-0.8332	0.2063	4	136	196	13	2007.1538
474	cofilin	-0.5299	0.088	3	114	160	12	2010.5
475	cognitive assessment	1.161	0.0523	2	237	375	16	2013.0625
476	cognitive change	1.0137	0.0895	2	346	590	30	2009.9333
477	cognitive deterioration	0.5885	-0.1643	2	311	461	31	2009.8065
478	cognitive disorder	0.3777	-0.3256	1	301	502	33	2009.6364
479	cognitive domain	0.6415	-0.2052	2	189	282	16	2010.75
480	cognitive enhancer	-0.2846	-0.4702	1	59	62	10	2010.5
481	cognitive functioning	0.7062	-0.36	2	165	219	13	2009.9231
482	cognitive improvement	-0.2668	-0.4456	1	169	194	15	2013.3333
483	cognitive measure	1.2203	0.0998	2	218	384	17	2010.1765
484	cognitive performance	0.5125	-0.3527	2	695	1548	90	2010.6
485	cognitive score	1.2372	-0.1225	2	274	467	25	2010
486	cognitive status	0.7948	0.0302	2	286	440	27	2008.6667
487	cognitive symptom	0.6229	-0.2939	2	364	566	32	2010.6562
488	cognitive test	0.9482	-0.2274	2	207	295	14	2009.6429
489	cognitively	1.295	0.0154	2	291	577	29	2011.0345
490	cohort	1.139	0.1588	2	1012	4270	217	2011.7972
491	cohort study	1.3146	0.0495	2	384	834	36	2011.9444
492	coiled body	0.0379	0.5385	3	213	385	20	2005.25
493	colleague	0.3615	0.1169	3	71	77	10	2009.3
494	collection	0.9277	-0.3218	2	313	538	32	2010.1875
495	colocalization	-0.4598	0.2664	3	418	732	51	2005.2941
496	colocalize	-0.558	0.121	3	162	196	13	2005.0769
497	combination	0.567	-0.1214	2	1460	5970	353	2008.8357
498	community	0.5653	-0.076	2	426	691	47	2009.5106
499	comparative study	0.4926	0.1767	3	171	210	14	2002.5714
500	complex disease	-0.1235	-0.3805	1	58	62	10	2009.9
501	complex disorder	0.144	-0.2893	1	143	214	16	2008
502	computer	0.4131	-0.0202	2	173	199	14	2003.6429
503	concomitant	-0.7978	-0.0904	1	172	201	16	2008.9375
504	confidence interval	1.2804	0.2249	2	341	756	37	2010.2973
505	confidence interval ci	1.2261	-0.0047	2	179	252	11	2010.1818
506	confirmation	0.6496	0.1155	2	381	621	30	2010.3
507	confocal laser scanning microscopy	-0.5735	0.1286	1	109	120	10	2008
508	confocal microscopy	-0.5286	0.2253	3	338	547	37	2006.7027
509	conformation	-0.8691	0.2308	4	708	2106	152	2006.125
510	conformational change	-0.8088	0.2043	4	580	1291	90	2006.7
511	congo	-0.3174	0.379	3	189	232	20	2003.75
512	congophilic angiopathy	-0.1531	0.27	3	96	127	12	2001.1667
513	consecutive patient	1.4202	-0.2201	2	234	517	20	2008.7
514	consensus	0.4773	-0.191	2	261	395	27	2010.6296
515	consortium	0.6655	0.2641	3	283	453	26	2009.6154
516	construct	-0.9345	0.2364	4	313	566	40	2005.5
517	continuum	0.6721	-0.0717	2	258	365	25	2010.96
518	control brain	-0.5383	0.4161	3	607	1384	102	2001.451
519	control case	-0.3595	0.3782	3	498	912	69	2003.2319
520	control group	0.863	-0.1415	2	691	1762	101	2007.5842
521	control mouse	-0.3585	-0.3903	1	319	467	42	2011.2857
522	control participant	1.2421	0.184	2	183	273	13	2012.8462
523	control sample	0.7303	0.5524	2	235	367	22	2007.5455
524	control subject	0.878	0.0893	2	850	2477	147	2006.9116
525	conversion	0.9253	-0.23	2	830	2450	124	2009.5161
526	core	-0.6599	0.407	4	689	1617	122	2003.1393
527	cornu ammonis	-0.332	0.3078	3	160	226	15	2006.9333
528	corpus callosum	0.8872	0.1868	2	151	187	12	2007.6667
529	correction	1.0305	0.2836	2	368	632	33	2009.1515
530	correlation	0.7387	0.1094	2	1350	5599	356	2007.8624
531	cortical area	-0.0573	0.4274	3	399	713	54	2000.8519
532	cortical atrophy	0.504	0.3769	3	283	399	25	2006.92
533	cortical lewy body	0.0577	0.4881	3	162	217	14	2000.5
534	cortical neuron	-0.6732	-0.2112	1	620	1296	92	2006.0761
535	cortical region	0.4904	0.2218	3	430	696	46	2005.7391
536	cortical thickness	1.1768	0.1044	2	238	475	19	2013.2632
537	corticobasal degeneration	0.0735	0.5601	3	839	2987	167	2005.7305
538	corticobasal syndrome	0.4921	0.4545	3	218	451	24	2011.7917
539	cos	-0.8358	0.3024	4	106	143	11	2002.5455
540	cost	0.2319	-0.2996	1	373	629	36	2008.7222
541	cotton wool plaque	-0.0281	0.4304	3	132	179	16	2005.8125
542	covariate	1.3292	0.1636	2	287	555	23	2010.4783
543	cpib	0.866	0.1499	2	122	184	11	2013.0909
544	cr1	0.9992	0.3374	2	143	318	13	2012.5385
545	creb	-0.6169	-0.3759	1	249	374	24	2011.75
546	creutzfeldt jakob disease	0.4596	0.3374	3	438	885	58	2008.1379
547	criterium	0.703	0.1656	2	991	3688	200	2007.845
548	crmp2	-0.8319	-0.3646	1	106	141	10	2010.9
549	cross reactivity	-0.7973	0.5435	4	183	279	17	1998.9412
550	cross sectional study	1.2888	-0.1185	2	353	668	27	2010.3333
551	cross talk	-0.5306	-0.309	1	78	86	10	2011.7
552	crosstalk	-0.7041	-0.1162	1	121	143	12	2009
553	crucial role	-0.6973	-0.1034	1	446	728	59	2009.4746
554	csf	1.2023	-0.1888	2	1480	21025	1104	2009.5761
555	csf abeta	1.3681	0.0843	2	606	2105	96	2010.8125
556	csf abeta1	1.4811	-0.0544	2	410	1177	53	2012.8491
557	csf abeta42	1.3919	-0.1383	2	582	1971	95	2010.0316
558	csf abeta42 level	1.425	-0.1557	2	284	555	26	2009.6154
559	csf ad biomarker	1.3477	-0.2045	2	262	502	19	2013
560	csf amyloid beta	1.2958	-0.1721	2	259	487	24	2011.5833
561	csf analysis	1.1675	0.1472	2	317	630	33	2010
562	csf beta	1.4336	-0.0965	2	267	511	23	2008.0435
563	csf biomarker	1.3233	-0.1254	2	904	6892	324	2011.3704
564	csf biomarker level	1.406	0.0346	2	328	715	30	2011.5
565	csf concentration	1.2059	-0.3409	2	470	1403	68	2009.6471
566	csf level	1.2579	-0.0969	2	825	3884	199	2009.0302
567	csf marker	1.34	-0.1634	2	540	1845	85	2009.3059
568	csf measure	1.4898	0.0044	2	349	849	35	2009.5714
569	csf p	1.4389	-0.0382	2	297	592	26	2010.4231
570	csf p tau	1.4533	-0.0487	2	313	674	31	2010.0968
571	csf profile	1.3521	0.1671	2	246	492	25	2010.56
572	csf sample	1.2855	-0.2612	2	601	2086	104	2009.875
573	csf t	1.3325	-0.2272	2	274	523	22	2010.8182
574	csf t tau	1.4181	-0.0532	2	265	509	24	2010.75
575	csf tau	1.3136	-0.0119	2	653	2272	118	2006.6186
576	csf total tau	1.2797	-0.1487	2	398	936	43	2009.5116
577	culture	-0.702	-0.1921	1	687	1438	112	2006.3839
578	cultured cell	-0.7762	0.0097	4	324	503	37	2008.027
579	cultured cortical neuron	-0.6564	-0.4922	1	137	207	15	2012.2667
580	cultured hippocampal neuron	-0.7838	-0.2288	1	131	182	12	2006.8333
581	cultured neuron	-0.7695	-0.2963	1	363	569	42	2008.2619
582	curcumin	-0.284	-0.4442	1	201	237	21	2011.7143
583	curly fiber	-0.4262	0.5441	3	75	113	12	1992.6667
584	current research	0.1518	-0.2231	1	138	158	14	2009.7143
585	current state	0.7161	-0.3426	2	165	214	14	2010.1429
586	current status	0.1669	-0.3503	1	136	162	14	2008.3571
587	current therapeutic strategy	-0.3381	-0.319	1	78	85	10	2010.7
588	current treatment	0.0299	-0.39	1	115	154	15	2009.6
589	current understanding	-0.5218	-0.0774	1	152	200	22	2007.3182
590	curve	1.4239	-0.2484	2	323	661	28	2011.8571
591	cut	1.1037	-0.3228	2	229	385	20	2009.2
592	cutoff	1.3965	-0.2006	2	316	719	29	2009.9655
593	cutoff value	1.4234	-0.2688	2	267	516	22	2009.5909
594	cvd	0.6497	-0.1105	2	108	156	11	2007
595	cyclin	-1.0293	0.0516	4	131	200	14	2001.3571
596	cyclin dependent kinase	-0.8684	-0.2974	1	615	1726	115	2007.4957
597	cyclin dependent protein kinase	-1.0742	-0.097	4	140	215	10	2008.3
598	cystatin c	1.136	-0.0117	2	151	233	13	2009.4615
599	cytoplasm	-0.5027	0.2489	3	638	1395	93	2004.2688
600	cytoplasmic inclusion	-0.0533	0.4729	3	241	406	23	2005.8261
601	cytoskeletal abnormality	-0.3668	0.2686	3	262	360	29	1999.931
602	cytoskeletal alteration	-0.3333	0.3795	3	132	178	18	2000.7778
603	cytoskeletal change	-0.3149	0.4355	3	245	411	31	2001.1935
604	cytoskeletal pathology	-0.3665	0.4612	3	239	395	32	1997.5625
605	cytoskeletal protein	-0.6445	0.3773	4	384	675	50	1999.24
606	cytoskeleton	-0.6872	0.1067	4	426	844	68	2001.9265
607	cytosol	-0.8909	0.0248	4	260	364	25	2005.68
608	cytotoxicity	-0.6873	-0.1181	1	338	513	44	2009.4773
609	daily living	0.3987	-0.3262	1	228	319	21	2009.9524
610	dat	1.1875	0.1243	2	271	468	29	2004.1379
611	database	1.1423	0.1097	2	406	900	52	2011.8269
612	definite ad	0.8953	0.2182	2	182	241	14	2006.7143
613	definite diagnosis	0.6895	0.0952	2	146	194	12	2006.9167
614	definitive diagnosis	0.57	0.0718	2	184	256	16	2005
615	degenerating process	-0.1728	0.579	3	151	223	17	1998.6471
616	degenerative dementia	0.5021	0.2859	3	227	341	20	2004
617	degenerative dementias	0.4046	0.2246	3	149	206	13	1999.9231
618	degrees c	-0.961	0.3561	4	356	659	40	2003.325
619	delusion	0.3378	0.2903	3	111	132	11	2007.8182
620	demented patient	0.4349	0.2695	3	299	465	31	2001.4194
621	dementia disorder	0.826	0.0878	2	290	468	22	2004.8636
622	dementia group	1.1971	-0.0061	2	238	417	21	2009
623	dementia patient	1.0702	-0.2253	2	387	847	48	2009.375
624	dementia pugilistica	-0.1139	0.4058	3	78	90	10	2004.1
625	dementia severity	0.9368	0.1392	2	256	423	25	2006.88
626	dementia syndrome	0.7521	0.0025	2	244	388	19	2009.0526
627	dementia worldwide	-0.0226	-0.3518	1	117	144	14	2013
628	dementias	0.6791	0.0622	2	794	2216	136	2007.4485
629	demographic	1.0175	0.1518	2	188	277	14	2012.0714
630	dendrite	-0.4496	0.3598	3	576	1336	102	2002.049
631	dendritic spine	-0.5794	-0.1448	1	238	344	32	2012.2812
632	dependent kinase	-0.9158	-0.1899	1	287	567	35	2002.7429
633	dependent protein kinase	-1.113	0.0218	4	261	531	36	2001.3611
634	dephosphorylation	-1.0516	0.1024	4	749	2487	146	2002.4589
635	depression	0.5932	-0.2691	2	639	1364	86	2010.1744
636	depressive symptom	1.1182	-0.0724	2	148	212	11	2010.8182
637	deregulation	-0.7773	-0.2147	1	452	811	59	2009.4407
638	destabilization	-0.8404	0.035	4	198	282	20	2007
639	determination	0.7202	-0.1467	2	435	746	44	2008.5227
640	devastating disease	-0.2187	-0.2376	1	214	269	28	2010.1071
641	dha	-0.4289	-0.4671	1	129	179	13	2010.8462
642	diabete	-0.4437	-0.554	1	447	942	73	2010.1644
643	diabetes	-0.4366	-0.5691	1	606	1406	98	2011.6735
644	diabetes mellitus	-0.4289	-0.5602	1	446	924	65	2010.2923
645	diabetic patient	-0.4344	-0.5483	1	131	183	13	2011.3077
646	diagnosis	0.917	-0.0949	2	1426	10833	644	2008.5714
647	diagnostic	0.4608	-0.1553	2	359	568	37	2009.8919
648	diagnostic accuracy	1.3353	-0.2983	2	582	2200	96	2009.4479
649	diagnostic biomarker	1.0714	-0.2787	2	337	653	39	2010.3333
650	diagnostic criterium	0.7962	0.0088	2	568	1481	78	2008.7179
651	diagnostic group	1.3501	-0.0776	2	390	901	41	2009.6098
652	diagnostic marker	1.133	-0.3257	2	529	1405	80	2006
653	diagnostic method	0.6424	-0.319	2	191	285	17	2008.9412
654	diagnostic performance	1.2289	-0.3748	2	215	423	20	2010.95
655	diagnostic sensitivity	1.2385	-0.3492	2	163	286	14	2005.4286
656	diagnostic test	0.9682	-0.1826	2	298	556	31	2004.7097
657	diagnostic tool	0.6847	-0.2588	2	435	861	55	2009.0364
658	diagnostic value	1.1799	-0.2158	2	402	1075	56	2008.9107
659	diameter	-0.4161	0.4838	3	245	410	31	1999.4516
660	diet	-0.3859	-0.4646	1	407	715	68	2011.4706
661	dietary supplementation	-0.4324	-0.4549	1	117	139	11	2011.1818
662	differential diagnosis	1.0152	-0.206	2	615	2296	126	2008.2778
663	differential expression	-0.1773	0.521	3	167	207	13	2003.0769
664	differentiate ad	1.4036	-0.2686	2	173	261	12	2009.5
665	differentiated neuron	-0.7892	-0.1179	1	104	133	11	2003.0909
666	diffuse	-0.158	0.4238	3	204	283	21	2000.8571
667	diffuse deposit	-0.1266	0.3908	3	151	223	19	1999
668	diffuse lewy body disease	0.0015	0.4999	3	190	290	17	1998.3529
669	diffuse plaque	-0.1236	0.3571	3	351	560	43	2001.6512
670	diffusion tensor imaging	1.0722	0.1045	2	231	415	16	2013.3125
671	digestion	-0.7737	0.3779	4	237	376	25	1999.12
672	dimensional gel electrophoresis	-0.7132	0.3821	4	161	195	14	2004.5
673	dimer	-0.8332	0.2497	4	327	575	39	2006.9744
674	direct evidence	-0.9124	0.0307	4	201	274	19	2008.0526
675	direct interaction	-0.6357	-0.0466	1	125	156	13	2009
676	direct link	-0.534	0.3145	4	150	220	17	2006.2353
677	discrimination	1.1937	-0.2883	2	452	1174	60	2008.1833
678	disease biomarker	1.4633	0.0107	2	263	534	30	2012.4
679	disease brain	-0.6865	0.3033	4	872	2371	181	2003.442
680	disease control	-0.2089	0.1174	3	160	225	13	2003.7692
681	disease course	0.6752	0.1716	2	253	332	23	2008.3478
682	disease dementia	0.6854	0.2384	3	336	554	27	2011.5926
683	disease diagnosis	1.2349	-0.3037	2	173	297	20	2010.7
684	disease duration	0.7467	0.2785	3	392	729	41	2007.6829
685	disease marker	0.8786	0.0663	2	197	282	19	2009.5263
686	disease model	-0.4547	-0.1816	1	331	466	40	2010.825
687	disease modification	0.1688	-0.3918	1	163	213	16	2008.75
688	disease modifying	0.5327	-0.2749	2	222	299	18	2010.1667
689	disease modifying drug	0.7201	-0.094	2	308	566	33	2011.2727
690	disease modifying effect	0.0454	-0.4129	1	159	199	11	2011.5455
691	disease modifying therapy	0.1274	-0.3538	1	302	413	32	2010.9375
692	disease modifying treatment	0.6643	-0.4014	2	166	249	15	2011.0667
693	disease mouse	-0.358	-0.4076	1	174	257	22	2011.5909
694	disease mouse model	-0.4397	-0.4256	1	198	254	24	2012.3333
695	disease neuroimaging initiative	1.3698	0.1257	2	528	2394	96	2012.4062
696	disease pathophysiology	-0.3432	-0.3176	1	74	83	14	2008.7857
697	disease research center	1.2321	0.0909	2	267	480	19	2011.7895
698	disease risk	0.8456	0.4716	2	162	282	22	2009.1818
699	disease severity	1.0125	0.0501	2	458	965	48	2010
700	disease stage	1.0365	-0.0311	2	397	730	39	2010.7949
701	disease treatment	-0.2337	-0.4716	1	95	110	11	2010.2727
702	diseased brain	-0.7303	0.1644	4	278	411	29	2004.069
703	disinhibition	0.4845	0.3755	3	221	335	18	2009.0556
704	disordered protein	-0.9397	0.2233	4	117	184	17	2010.8235
705	dissociation	-0.8188	0.0373	4	329	485	34	2006.3824
706	distinction	0.3061	0.2483	3	353	569	37	2006.7568
707	distribution pattern	-0.0663	0.4142	3	252	335	25	2004.88
708	dlb	0.514	0.3161	3	665	1835	109	2008.0092
709	dlb case	0.3441	0.4398	3	137	190	11	2009.1818
710	dlb patient	1.0981	-0.1767	2	175	338	20	2009.25
711	dna damage	-0.6461	-0.2521	1	195	267	26	2008
712	dna fragmentation	-0.3434	0.2419	3	240	428	25	2002.24
713	docosahexaenoic acid	-0.4301	-0.466	1	147	202	15	2010.8667
714	domain	-0.7975	0.1081	4	987	2633	184	2006.163
715	donepezil	0.002	-0.4063	1	301	493	29	2010
716	dose dependent manner	-0.6446	-0.47	1	277	416	25	2008.8
717	double blind	0.4625	-0.5321	1	247	570	25	2011.2
718	double immunostaining	-0.1884	0.4905	3	139	172	10	2003.1
719	double labeling	-0.3731	0.4187	3	162	214	16	1999.5625
720	double labeling immunohistochemistry	-0.3769	0.3915	3	131	208	11	2000.7273
721	double staining	-0.3834	0.328	3	168	206	13	2005.3077
722	double transgenic mouse	-0.5235	-0.3436	1	199	299	22	2009.5909
723	down regulation	-0.8908	-0.3694	1	172	255	18	2009.5
724	downregulation	-0.6583	-0.41	1	406	724	50	2010.46
725	drinking water	-0.4048	-0.4569	1	113	143	13	2008.6923
726	drosophila	-0.6291	-0.1232	1	209	329	32	2010.7812
727	drosophila model	-0.6453	-0.1368	1	156	239	23	2010.6087
728	drug administration	0.0306	-0.4061	1	187	226	14	2009.6429
729	drug development	0.0915	-0.3266	1	458	795	60	2009.2667
730	drug target	-0.3087	-0.2844	1	311	458	48	2010.6042
731	ds brain	-0.6632	0.3138	4	123	160	10	2006.4
732	dti	1.0701	0.1007	2	153	238	10	2013.7
733	duration	0.5688	0.1485	3	666	1456	92	2006.2283
734	dyrk1a	-0.8184	0.0691	4	173	298	21	2011.1429
735	dystrophic neurite	-0.3743	0.4057	3	936	3100	229	2001.2838
736	e genotype	1.217	0.1958	2	250	414	22	2002.9091
737	early	0.6075	0.3256	3	141	151	11	2008.4545
738	early ad	0.8949	-0.1927	2	380	707	34	2009.6765
739	early ad diagnosis	1.2813	-0.3345	2	159	216	12	2012
740	early alzheimer	0.9387	-0.1664	2	383	659	45	2009.1778
741	early alzheimer disease	1.2592	0.0049	2	163	226	10	2010.5
742	early detection	0.7543	-0.2358	2	454	1005	54	2009.1667
743	early diagnosis	0.8173	-0.2317	2	718	2043	128	2009.2188
744	early intervention	0.2105	-0.3693	1	184	239	18	2010.5556
745	early onset ad	0.6235	0.283	2	188	245	20	2007.35
746	early onset alzheimer	0.5695	0.4321	3	321	491	33	2006.3636
747	early stage alzheimer	0.6868	0.0311	2	152	185	11	2010.1818
748	education	1.1661	0.0367	2	443	1040	51	2009.1961
749	eeg	0.6466	0.16	3	208	270	14	2008
750	effective disease	0.0533	-0.3787	1	130	151	13	2012.5385
751	elderly control	0.6013	0.1501	2	341	523	30	2005.9667
752	elderly patient	0.6486	-0.1801	2	303	441	28	2005.5714
753	elderly population	0.2514	-0.3181	1	185	228	16	2011.0625
754	electron microscopy	-0.733	0.2934	4	543	1165	85	2004.1059
755	electrophoretic mobility	-1.037	0.3982	4	238	451	25	1995.28
756	elisa	0.9025	-0.3546	2	878	2989	175	2008.2629
757	elisa assay	0.933	-0.3692	2	180	265	15	2007.8667
758	elisas	1.0566	-0.4146	2	193	325	19	2008.4211
759	endogenous tau	-0.7539	-0.0599	1	217	321	25	2011.72
760	endophenotype	0.9868	0.417	2	154	262	16	2013.3125
761	endoplasmic reticulum	-0.7034	-0.245	1	358	620	47	2010.4255
762	endoplasmic reticulum stress	-0.7065	-0.2542	1	135	177	14	2011.5
763	endpoint	0.3886	-0.4218	1	355	583	35	2010.4857
764	energy metabolism	-0.4529	-0.5376	1	353	597	49	2009.4898
765	environmental enrichment	-0.2559	-0.4361	1	103	122	10	2011.3
766	eoad	0.558	0.4557	3	162	252	16	2010.6875
767	epidemiology	0.2474	-0.2642	1	197	289	22	2007.8636
768	epigenetic change	-0.4179	-0.2521	1	75	81	10	2012.8
769	episodic memory	1.0166	0.0243	2	362	675	38	2009.2632
770	epitope	-0.7468	0.4071	4	1196	5682	370	2000.9784
771	epsilon4	1.1328	0.3437	2	280	526	29	2006.5517
772	epsilon4 allele	1.0394	0.3414	2	362	714	41	2007.5854
773	er stress	-0.7132	-0.255	1	141	231	17	2012.0588
774	erk	-0.7877	-0.2821	1	376	731	45	2006.0889
775	erk1	-0.8598	-0.2383	1	298	499	28	2006.9643
776	error	0.9221	0.1071	2	318	495	25	2010.72
777	essential role	-0.7276	-0.1186	1	222	296	25	2007.64
778	estimate	1.0778	-0.0432	2	326	560	29	2010.069
779	europe	0.8587	-0.0322	2	251	443	20	2007.85
780	evaluation	0.6586	-0.0474	2	1123	3608	216	2009.1898
781	exacerbation	-0.4103	-0.4323	1	112	131	15	2012.9333
782	exact mechanism	-0.4344	-0.2704	1	164	207	15	2011.4667
783	excitotoxicity	-0.4685	-0.3392	1	362	575	49	2010.449
784	exclusion	0.5959	0.0149	2	199	288	19	2009.7368
785	executive function	0.9474	0.0786	2	336	656	34	2011.8824
786	exon	-0.0846	0.5741	3	615	1462	96	2004.7188
787	experience	0.3351	-0.2461	2	284	398	23	2008
788	experimental animal	-0.5398	-0.0936	1	135	181	15	2005.6
789	experimental approach	-0.1994	-0.2755	1	133	141	15	2007.1333
790	expert opinion	-0.0714	-0.3049	1	141	172	14	2013.1429
791	extensive study	-0.5589	-0.1158	1	105	123	10	2006.1
792	extracellular matrix	-0.5682	0.0781	1	144	173	14	2007.3571
793	extracellular signal	-0.8516	-0.2275	1	287	487	29	2005.4483
794	extracellular tangle	-0.5142	0.4435	3	196	275	19	1998.6842
795	familial case	0.0316	0.3219	3	224	313	24	2004.2083
796	familial frontotemporal dementia	0.0399	0.5961	3	183	308	17	2004.2941
797	family history	0.6555	0.4441	3	342	617	35	2007.5143
798	fat	-0.4894	-0.418	1	178	248	16	2011.4375
799	fda	-0.0498	-0.3699	1	197	268	19	2009.7368
800	fdg	1.0648	0.0789	2	317	691	29	2012.1034
801	fdg pet	1.1559	0.0786	2	430	1211	54	2011.537
802	female	0.4476	-0.0011	2	545	1156	76	2009.1316
803	female mouse	-0.3129	-0.4642	1	158	221	19	2010.9474
804	fetal	-0.9517	0.4317	4	220	402	24	1997.3333
805	fetal brain	-0.9528	0.3765	4	163	247	15	1998.2667
806	fetal tau	-1.0209	0.4119	4	223	487	28	1997.6429
807	fiber	-0.4955	0.2799	3	520	1101	88	2001.8068
808	fibril	-0.6081	0.1801	4	906	2323	187	2006.3422
809	fibril formation	-0.796	0.235	4	238	368	30	2008.1333
810	fibrillar aggregate	-0.7245	0.056	4	196	244	21	2009.9524
811	fibrillization	-0.8094	0.2302	4	211	438	35	2009.0286
812	filament	-0.7742	0.3255	4	886	3127	230	2002.2087
813	filament formation	-0.8885	0.2743	4	254	547	35	2004.7143
814	filamentous aggregate	-0.6882	0.2806	4	136	178	14	2002.8571
815	filamentous inclusion	-0.4918	0.5142	4	202	302	20	2002.8
816	filamentous structure	-0.8357	0.3511	4	178	241	15	2002.0667
817	filamentous tau	-0.7652	0.3038	4	113	138	11	2008.6364
818	first demonstration	-0.2708	0.1095	3	196	272	17	2002.2353
819	fluorescence	-0.821	0.2624	4	300	538	41	2006.6829
820	fluorodeoxyglucose positron emission tomography	1.1811	0.0819	2	171	260	11	2010.6364
821	fly	-0.6191	-0.1436	1	99	131	16	2010.5
822	folding	-0.7392	0.0717	4	309	499	40	2009.725
823	food	-0.2146	-0.4395	1	198	274	25	2011.04
824	formic acid	-0.6226	0.4775	4	229	339	22	1999.5455
825	foundation	0.7792	-0.05	2	236	346	20	2010.8
826	fraction	-0.678	0.361	4	897	2449	169	2003.0828
827	fragmentation	-0.7635	-0.0813	1	301	455	29	2009.6552
828	free radical	-0.3771	-0.2949	1	269	373	39	2007.641
829	frequency	0.5336	0.4562	3	754	1983	136	2005.3015
830	frequent cause	0.2275	0.3041	3	138	158	11	2005.0909
831	frontal lobe	0.1702	0.4349	3	272	359	24	2005.4583
832	frontotemporal degeneration	0.6702	0.2913	3	181	249	14	2008
833	frontotemporal dementia	0.2582	0.4492	3	1239	5126	310	2007.5613
834	frontotemporal dementias	-0.1354	0.5492	3	256	385	26	2005.2308
835	frontotemporal lobar degeneration	0.4459	0.4941	3	738	2321	138	2010.5797
836	ftd	0.5947	0.4339	3	723	2060	119	2007.6471
837	ftd patient	0.8631	0.2875	2	191	279	14	2009.2857
838	ftdp	-0.2536	0.512	3	631	1637	99	2006.3535
839	ftld	0.4972	0.486	3	615	1783	102	2010.4706
840	ftld tau	0.4933	0.4989	3	158	262	13	2012.6923
841	ftld tdp	0.4784	0.5035	3	168	314	17	2011.5882
842	ftld u	0.3165	0.5137	3	142	236	13	2008.9231
843	full length	-0.7964	0.2153	4	587	1162	75	2008.1067
844	full length tau	-0.8942	0.247	4	286	438	27	2006.9259
845	functional decline	0.8323	-0.0132	2	177	226	14	2010.9286
846	funding	0.9851	0.0121	2	209	332	13	2011.3846
847	further development	-0.3187	-0.3239	1	134	146	13	2010.0769
848	further elucidation	0.1283	0.369	3	130	150	10	2004.9
849	further research	0.5422	-0.3915	2	201	256	14	2011.6429
850	future	0.2426	-0.2926	1	451	804	69	2008.4058
851	future clinical trial	0.8905	-0.0662	2	177	218	11	2011.6364
852	future decline	1.0733	0.024	2	167	330	11	2011.4545
853	future development	0.8486	-0.3487	2	218	345	17	2010.0588
854	future treatment	0.3	-0.3662	1	123	148	13	2007.5385
855	fyn	-0.7256	-0.0938	1	278	450	33	2010.9394
856	g protein	-0.5098	-0.1962	1	164	242	21	2006.5714
857	galantamine	0.011	-0.4013	1	238	399	25	2009.2
858	gallyas	-0.143	0.459	3	259	414	27	2001.7037
859	gamma secretase activity	-0.4147	-0.2742	1	182	242	21	2009.4286
860	gamma secretase complex	-0.5038	-0.2617	1	102	124	11	2011.1818
861	gel	-0.8559	0.4514	4	278	529	29	1997.2069
862	gel electrophoresis	-0.7655	0.4005	4	347	565	37	2004.5405
863	gender	1.1062	0.1687	2	588	1580	85	2009.8941
864	gene mutation	0.0474	0.311	3	393	704	60	2007.65
865	gene transcription	-0.5983	-0.2235	1	128	153	11	2008.1818
866	general population	0.3776	-0.2504	2	159	201	12	2007.4167
867	genetic analysis	0.4319	0.4404	3	268	369	26	2006.1154
868	genetic association	0.9836	0.4533	2	173	321	20	2007.6
869	genetic background	0.2452	0.3169	3	194	259	19	2007.7895
870	genetic cause	0.4193	0.3158	3	135	169	17	2007.6471
871	genetic marker	1.0072	0.3809	2	164	257	16	2007.5
872	genetic risk	0.9237	0.3333	2	247	352	19	2008.3158
873	genetic risk factor	0.8109	0.3765	2	439	836	65	2009.7692
874	genetic testing	0.5623	0.4112	3	134	158	10	2009.6
875	genetic variant	0.8155	0.452	2	314	534	31	2010.9032
876	genetic variation	0.7879	0.481	2	274	459	28	2010.1786
877	genome	0.0713	-0.2728	1	215	317	24	2008.9167
878	genome wide association study	0.8147	0.4412	2	260	494	28	2012.5714
879	genotype	0.7666	0.3374	2	853	2641	153	2007.5163
880	ghost tangle	-0.3052	0.4422	3	191	306	20	2001.35
881	glcnac	-0.9417	-0.1366	4	107	163	14	2010.6429
882	glcnacylation	-0.9431	-0.1374	4	91	136	10	2009.3
883	glia	-0.259	0.3036	3	422	614	42	2005.5714
884	glial activation	-0.332	-0.3841	1	238	325	26	2010.3077
885	glial cell	-0.3101	0.2428	3	623	1319	88	2004.6818
886	glial cytoplasmic inclusion	-0.0822	0.5161	3	128	186	11	2003.9091
887	glial inclusion	-0.0327	0.524	3	248	401	19	2004.8947
888	globus pallidus	0.1026	0.4877	3	135	182	11	2003.5455
889	glp	-0.451	-0.5845	1	148	306	18	2012.6667
890	glu	-0.9513	0.1951	4	126	172	11	2004.8182
891	glucagon	-0.4477	-0.5849	1	149	290	16	2012.875
892	glutamate	-0.3711	-0.2265	1	360	525	38	2007.1053
893	glutamate receptor	-0.5341	-0.2684	1	216	296	22	2010.3636
894	glycation	-0.8272	0.1344	4	235	417	34	2004.5882
895	glycation end product	-0.2788	-0.2845	1	284	466	40	2007.7
896	glycogen synthase kinase	-0.8556	-0.3815	1	892	3055	201	2006.607
897	glycogen synthase kinase 3beta	-0.7904	-0.377	1	847	2608	166	2008.988
898	glycosaminoglycan	-0.5381	0.3781	4	147	196	18	2000
899	glycosylation	-0.8637	0.1262	4	236	374	28	2006.2857
900	grain	0.0368	0.5533	3	179	297	17	2002.5882
901	granule	-0.4388	0.3096	3	409	770	52	2004.1154
902	granulovacuolar degeneration	-0.4341	0.3171	3	255	476	31	2003.1935
903	greater extent	-0.2888	0.5418	3	129	144	10	2002.5
904	grey matter	0.7351	0.231	2	253	377	22	2006.5455
905	grn	0.4783	0.4983	3	214	404	22	2012.2273
906	group	0.5577	-0.0256	2	1861	12945	796	2008.4925
907	group difference	1.102	-0.4287	2	177	287	14	2011.5714
908	gsk	-0.9517	-0.3327	1	741	2489	158	2005.8861
909	gsk 3beta	-0.8221	-0.3914	1	776	2266	146	2009.1849
910	gsk 3beta activity	-0.7795	-0.5102	1	180	317	18	2009.8333
911	gsk3	-0.8201	-0.4163	1	288	506	39	2007.8718
912	gsk3b	0.2165	-0.2615	1	173	240	13	2010.3846
913	gsk3beta	-0.7367	-0.3865	1	670	1680	111	2010.3243
914	gsk3beta activity	-0.7323	-0.4091	1	213	346	24	2009.9583
915	guam	-0.1239	0.5196	3	205	329	25	2001.72
916	guideline	0.8168	-0.1735	2	274	469	27	2010.6296
917	gvd	-0.4385	0.3173	3	177	280	16	2005.1875
918	gwas	0.9305	0.4412	2	135	227	13	2013.3077
919	h1 haplotype	0.6737	0.5618	3	162	299	17	2007.7059
920	h2o2	-0.721	-0.3526	1	128	166	10	2009.4
921	haplotype	0.703	0.5476	3	343	841	53	2007.0377
922	hazard ratio	1.4213	0.0114	2	250	531	21	2011.619
923	healthy aging	1.2719	0.0163	2	161	204	10	2010.9
924	healthy control	1.1945	-0.0726	2	763	2886	158	2009.8671
925	healthy control subject	1.2833	0.1504	2	177	289	15	2008.2
926	healthy elderly control	1.0663	0.0434	2	167	260	12	2011.25
927	healthy individual	1.0525	-0.2583	2	310	514	29	2009.5517
928	healthy older adult	1.4167	0.0885	2	150	231	10	2012
929	healthy subject	1.1583	-0.2847	2	294	504	29	2010.8621
930	heat	-0.9103	0.2908	4	210	320	17	1999.5882
931	heat shock	-0.7115	-0.0105	4	120	176	14	2003.7143
932	heat shock protein	-0.7059	-0.0153	4	195	274	26	2010
933	helical filament	-0.7921	0.4056	4	1331	8828	616	1998.9188
934	helical filament formation	-0.8171	0.3538	4	156	196	16	1999.9375
935	helical filament tau	-0.5631	0.445	4	326	531	40	2001.3
936	help	0.7215	-0.1753	2	271	406	25	2007.52
937	heme oxygenase	-0.598	-0.1728	1	117	149	12	2006.75
938	heparan sulfate proteoglycan	-0.553	0.3017	4	140	192	16	2002
939	heparin	-0.9416	0.2684	4	304	672	41	2006.0732
940	heterogeneous group	0.447	0.5313	3	177	231	13	2006.8462
941	high affinity	-0.3276	0.0591	4	220	326	25	2008.08
942	high csf tau	1.4665	-0.1094	2	148	228	11	2008.2727
943	high density	-0.0976	0.3752	3	201	245	18	2004.4444
944	high diagnostic accuracy	1.2078	-0.3056	2	187	296	14	2010.9286
945	high fat diet	-0.4179	-0.5606	1	210	344	24	2012.4583
946	high molecular weight	-0.8297	0.3995	4	123	146	11	2002.5455
947	high risk	0.7496	-0.3086	2	350	568	29	2010.1034
948	high sensitivity	1.049	-0.3334	2	292	550	28	2008.6071
949	high specificity	1.1055	-0.2668	2	135	194	11	2010.1818
950	higher frequency	0.3749	0.5094	3	158	193	12	2005.9167
951	higher risk	0.6003	-0.2441	2	289	439	27	2009.7407
952	higher tau	1.4349	0.0597	2	160	251	10	2010.3
953	hippocampal atrophy	1.2081	0.1493	2	434	1026	53	2011.8302
954	hippocampal dentate gyrus	-0.4199	-0.1004	1	117	139	11	2009.7273
955	hippocampal neuron	-0.5571	-0.011	1	645	1325	105	2007.4381
956	hippocampal pyramidal neuron	-0.4345	0.3016	3	135	185	12	2001.9167
957	hippocampal sclerosis	0.4189	0.4791	3	170	260	16	2008.9375
958	hippocampal section	-0.2579	0.3661	3	162	198	16	2006.375
959	hippocampal slice	-0.5872	-0.2861	1	250	365	28	2010
960	hippocampal volume	1.4392	0.0155	2	423	1329	56	2012.3929
961	hirano body	-0.4331	0.3258	3	156	227	17	2001.5882
962	histone deacetylase	-0.6224	-0.1906	1	88	113	12	2012.0833
963	hiv	0.7805	0.0589	2	147	189	12	2009
964	hne	-0.5525	-0.209	1	149	199	16	2008
965	homogenate	-0.5728	0.2313	4	383	626	42	2003.6429
966	homozygote	0.8484	0.3686	2	187	260	16	2005
967	hope	0.0015	-0.3308	1	307	437	36	2008.8611
968	hsp	-0.7039	-0.0191	4	135	178	14	2010.3571
969	hsp70	-0.7054	-0.0179	4	96	131	12	2011.3333
970	hsp90	-0.7012	-0.0219	4	85	114	10	2012.3
971	htau40	-0.9579	0.22	4	184	279	18	2005.3889
972	human amyloid precursor protein	-0.4543	-0.3243	1	285	399	38	2009.3684
973	human app	-0.452	-0.3167	1	183	253	25	2008.12
974	human cerebrospinal fluid	0.9116	-0.3924	2	253	426	27	2007.4815
975	human clinical trial	0.0696	-0.3548	1	88	107	11	2010.7273
976	human hippocampus	-0.3833	0.3032	3	110	129	13	2010.6154
977	human neuroblastoma cell	-0.8497	-0.0685	1	326	572	38	2004.6316
978	human neuron	-0.4885	-0.1253	1	192	270	20	2006.35
979	human tau	-0.7677	0.1433	4	800	2290	171	2006.5263
980	human tau protein	-0.877	0.3025	4	260	398	28	2000.7857
981	huntingtin	-0.4067	0.1222	3	117	148	15	2009.5333
982	huntington disease	-0.4045	0.1244	3	118	145	12	2007.5
983	hybridization	-0.488	0.0874	1	181	235	21	2005.0476
984	hydrogen peroxide	-0.6827	-0.3503	1	145	194	17	2009.4706
985	hydroxy	-0.5514	-0.2064	1	119	149	13	2008.3846
986	hyper phosphorylation	-0.6045	-0.4005	1	220	278	24	2011
987	hyperactivation	-0.54	-0.4888	1	187	241	15	2010.2667
988	hyperactivity	-0.4593	-0.4483	1	194	250	21	2012.1429
989	hyperglycemia	-0.4469	-0.5656	1	189	270	16	2010.75
990	hyperinsulinemia	-0.4307	-0.5758	1	139	233	16	2011.375
991	hyperphosphorylated	-0.8541	-0.0146	4	238	350	26	2005.1154
992	hyperphosphorylated form	-0.9671	0.0475	4	246	405	30	2007.7
993	hyperphosphorylated microtubule	-0.3535	0.4899	3	316	504	35	2004.8286
994	hyperphosphorylated state	-0.9814	0.3206	4	212	334	18	2001.0556
995	hyperphosphorylation	-0.7747	-0.3162	1	1641	9789	711	2008.0506
996	hypertension	0.3887	-0.2847	2	341	574	43	2009.9302
997	hypometabolism	0.9589	0.106	2	523	1257	64	2010.9219
998	hypoperfusion	0.4273	0.0324	2	324	479	32	2009.0938
999	hypothalamus	-0.1116	0.3328	3	221	329	25	2003.88
1000	hypothermia	-0.6105	-0.4676	1	170	267	19	2010.4737
1001	ibm	-0.2447	0.1152	3	117	235	18	2003.7222
1002	icv	-0.5025	-0.5285	1	222	374	27	2012.3704
1003	ide	-0.4661	-0.5246	1	135	166	11	2010.8182
1004	identifier	0.6496	-0.5335	2	138	242	11	2012.9091
1005	identity	-0.7168	0.294	4	191	240	18	2004.7222
1006	idiopathic normal pressure hydrocephalus	1.1416	-0.4399	2	95	162	10	2012.5
1007	igf	-0.4542	-0.5507	1	220	385	30	2009.2333
1008	il 1beta	-0.3108	-0.3809	1	125	141	11	2008.7273
1009	image	0.727	0.1674	2	499	1031	61	2009.3607
1010	image analysis	0.3304	0.3409	3	225	291	21	2005.5714
1011	imaging	0.6136	-0.0088	2	899	2687	171	2011.4386
1012	immunoblot	-0.6856	0.5271	4	501	1106	72	1999.2222
1013	immunoblot analysis	-0.6711	0.4508	4	410	691	41	2001.5366
1014	immunoblotting	-0.7262	0.435	4	240	352	26	2001.4231
1015	immunocytochemical study	-0.4609	0.478	3	154	207	17	1995.4118
1016	immunocytochemistry	-0.3213	0.3458	3	516	1035	77	1999.3247
1017	immunodetection	-0.1665	0.5776	3	124	184	14	1994.5714
1018	immunoelectron microscopy	-0.4423	0.4945	3	207	339	27	1999.2593
1019	immunofluorescence	-0.5771	0.3536	4	312	466	34	2004.7941
1020	immunohistochemical analysis	-0.401	0.1634	3	365	583	46	2007.913
1021	immunohistochemical staining	-0.2666	0.1587	3	286	388	27	2004.8148
1022	immunohistochemical study	-0.2514	0.4664	3	418	726	52	2001.3077
1023	immunolabeling	-0.4646	0.4209	3	305	548	40	2000.75
1024	immunological approach	0.0064	-0.3629	1	71	123	11	2008.6364
1025	immunoreactivity	-0.4294	0.3602	3	1242	5780	418	2001.4809
1026	immunosorbent assay	0.9642	-0.2945	2	616	1671	94	2006.9681
1027	immunostaining	-0.3268	0.401	3	505	912	69	2002.4348
1028	immunotherapy	0.0173	-0.36	1	433	938	86	2010.4186
1029	impaired insulin	-0.4525	-0.5748	1	116	178	11	2012
1030	implementation	0.3335	-0.3565	1	249	369	19	2011.6316
1031	important component	-0.3075	-0.1786	1	103	114	11	2006.9091
1032	inactivation	-0.8059	-0.2473	1	306	483	32	2007.8125
1033	inactive form	-0.862	-0.3372	1	143	184	10	2008.1
1034	incipient	1.3289	-0.1983	2	180	272	11	2009.4545
1035	incipient ad	1.1236	-0.3901	2	226	466	21	2005.6667
1036	inclusion	-0.0852	0.423	3	1068	3235	213	2006.6667
1037	inclusion body myositis	-0.2433	0.1147	3	80	121	12	2002.5
1038	increased phosphorylation	-0.7614	-0.4355	1	127	161	10	2008.9
1039	increased production	-0.3881	-0.1013	1	130	145	11	2006.7273
1040	incubation	-0.9922	0.1255	4	421	797	54	2003
1041	independent cohort	1.2254	0.0103	2	191	302	14	2012.5714
1042	index	0.9749	-0.0513	2	616	1392	85	2009.7176
1043	individual	0.6475	0.085	2	1656	8567	541	2008.353
1044	individual neuron	-0.3733	0.354	3	137	159	10	2003.7
1045	individual patient	0.9386	-0.1216	2	162	208	12	2011.25
1046	inducer	-0.821	0.1127	4	254	418	33	2008.9394
1047	induction	-0.5907	-0.1604	1	804	1676	145	2008.1862
1048	inferior temporal cortex	0.2066	0.3178	3	166	194	13	2007.1538
1049	inflammatory marker	-0.2537	-0.4769	1	184	236	20	2010.7
1050	inflammatory mediator	-0.3044	-0.4095	1	164	203	19	2011.8421
1051	inflammatory reaction	-0.2707	-0.3883	1	180	217	18	2007.4444
1052	influx	-0.5025	-0.3221	1	226	291	25	2007.76
1053	information	0.6019	-0.0812	2	976	2830	187	2009.5401
1054	inhibition	-0.669	-0.32	1	1362	5974	428	2009.3808
1055	inhibitory activity	-0.5712	-0.4977	1	144	234	17	2010.7647
1056	inhibitory effect	-0.8344	-0.1691	1	191	249	18	2010.7778
1057	initial stage	-0.7003	-0.0651	1	121	135	11	2005.6364
1058	innogenetics	1.3565	-0.3637	2	185	358	15	2008.3333
1059	innotest	1.4214	-0.3119	2	197	383	16	2011.4375
1060	insoluble aggregate	-0.8334	0.1223	4	169	233	21	2009.4286
1061	insoluble tau aggregate	-0.697	0.2204	4	99	116	10	2011.4
1062	insulin	-0.4583	-0.5585	1	663	1690	121	2010.0826
1063	insulin degrading enzyme	-0.4654	-0.5213	1	189	266	17	2011.0588
1064	insulin receptor	-0.4705	-0.5474	1	166	295	24	2008.8333
1065	insulin resistance	-0.4278	-0.569	1	387	832	66	2011.8333
1066	insulin signaling	-0.4654	-0.5719	1	274	592	43	2012.3256
1067	insult	-0.5981	-0.3014	1	445	720	63	2008.0159
1068	integral component	-0.7005	0.4171	4	125	176	13	1998.6154
1069	integration	0.7724	-0.0726	2	174	307	14	2010.5714
1070	interacting protein	-0.7328	-0.0202	4	216	305	27	2010.037
1071	intermediate	-0.7476	0.1397	4	238	314	29	2010.4483
1072	interpretation	0.8277	0.1163	2	830	1879	104	2010.0288
1073	interval	0.7517	-0.1055	2	484	912	49	2007.2857
1074	intracellular abeta	-0.44	-0.3074	1	174	233	19	2010.5263
1075	intracellular aggregate	-0.7749	0.0186	4	118	128	12	2010.0833
1076	intracellular inclusion	-0.5805	0.1794	4	162	194	19	2009.5789
1077	intracellular tangle	-0.5514	0.2734	3	175	237	17	2003.8824
1078	intracellular tau	-0.6685	0.098	4	80	92	11	2011.5455
1079	intracellular transport	-0.7639	-0.0124	4	137	167	13	2004.3846
1080	intracerebroventricular injection	-0.5145	-0.5435	1	115	166	11	2012.1818
1081	intraneuronal abeta	-0.4412	-0.3129	1	183	241	19	2008.4211
1082	intraneuronal inclusion	0.0215	0.4828	3	178	233	16	2003.9375
1083	intraperitoneal injection	-0.6219	-0.5409	1	172	241	17	2011.5882
1084	intravenous immunoglobulin	-0.1891	-0.3858	1	100	134	11	2013.6364
1085	intron	0.6822	0.5756	3	223	492	31	2005.2903
1086	investigator	0.5978	-0.1211	2	264	473	30	2006.3333
1087	ion	-0.7693	0.2636	4	192	246	22	2007.9091
1088	isocortex	-0.1598	0.3891	3	179	225	19	2000.7895
1089	isoflurane	-0.2239	-0.5206	1	83	118	10	2012
1090	isomerization	-1.0035	0.0308	4	196	371	21	2007.5238
1091	isoprostane	0.9339	-0.429	2	262	491	28	2007.6429
1092	ivig	-0.1892	-0.3859	1	100	134	11	2013.6364
1093	j biol	-0.7529	0.1039	4	145	199	13	2000.6154
1094	january	1.321	-0.0604	2	329	634	23	2011.1304
1095	japan	0.4541	0.2043	3	226	299	19	2005.1053
1096	jnk	-0.7716	-0.3464	1	507	1102	64	2008.2656
1097	kda	-0.7088	0.4962	4	630	1500	92	2000.6522
1098	kda band	-0.5653	0.6004	3	162	224	13	2001.7692
1099	kda fragment	-0.8685	0.4504	4	137	202	12	1999.5833
1100	kda protein	-1.0631	0.3432	4	106	157	12	1993
1101	key enzyme	-0.6403	-0.3233	1	213	268	18	2006.2778
1102	key regulator	-0.7017	-0.165	1	140	166	12	2007.5833
1103	key target	-0.5647	-0.497	1	94	107	11	2010.7273
1104	kinase	-0.9063	-0.1577	1	1356	7214	462	2006.0779
1105	kinase activity	-0.9407	-0.1558	4	446	970	62	2005.1129
1106	kind	-0.5143	0.0551	1	257	339	30	2005.5333
1107	kinesin	-0.7493	-0.0384	1	180	253	20	2007.1
1108	kinetic	-0.8689	0.2473	4	324	554	37	2008.2973
1109	knockdown	-0.7475	-0.2392	1	321	539	43	2012.186
1110	labeling	-0.4516	0.2845	3	604	1268	83	2004.8795
1111	language	0.5735	0.2526	3	333	547	35	2010.2571
1112	late onset ad	0.7057	0.4159	2	389	653	45	2008.8
1113	late onset alzheimer	0.7068	0.457	2	513	1047	81	2008.0123
1114	late onset alzheimer disease	0.7954	0.4579	2	128	157	12	2007.75
1115	late onset dementia	0.124	0.5363	3	151	210	15	2005.2
1116	layer	-0.1792	0.3909	3	523	1004	77	2002.8442
1117	lbd	0.3287	0.3868	3	276	432	24	2008.8333
1118	lbs	0.1422	0.4332	3	224	357	23	2003.8261
1119	learning	-0.4462	-0.4578	1	707	1567	131	2010.8244
1120	leptin	-0.5206	-0.508	1	124	179	16	2011.3125
1121	levels	0.6685	-0.3634	2	655	1483	89	2008.4944
1122	lewy body	0.3101	0.4001	3	1042	3986	251	2006.8048
1123	lewy body dementia	0.7337	0.024	2	356	676	39	2007.1282
1124	lewy body disease	0.2868	0.3949	3	409	728	44	2008.1136
1125	lewy body pathology	0.3021	0.4197	3	178	228	16	2007.625
1126	lewy body variant	0.2804	0.4274	3	111	151	10	2001.7
1127	lewy neurite	0.0915	0.4944	3	124	164	12	2006.5833
1128	licl	-0.9682	-0.3842	1	115	168	11	2006.2727
1129	likelihood	0.8305	0.1796	2	291	428	26	2011.7308
1130	limbic area	0.0792	0.4479	3	153	185	13	2003.3846
1131	limbic system	0.1506	0.4101	3	175	215	16	2005.5
1132	limit	0.4145	-0.1449	2	224	337	22	2009.6818
1133	linear mixed model	1.3892	0.0151	2	159	264	11	2012.9091
1134	linear regression	1.2844	0.184	2	283	517	22	2010.8182
1135	linear regression analysis	0.9428	0.2649	2	293	459	24	2007.0417
1136	lipid raft	-0.4649	-0.0648	1	152	174	16	2011.1875
1137	lipopolysaccharide	-0.3298	-0.4181	1	126	159	12	2011.0833
1138	lipoxygenase	-0.4494	-0.3851	1	102	153	15	2012.6667
1139	lithium	-0.5874	-0.5237	1	315	622	49	2007.4286
1140	lithium treatment	-0.2856	-0.6056	1	135	201	13	2010.2308
1141	localization	-0.5528	0.2221	3	732	1714	134	2004.1866
1142	localize	-0.6823	-0.0261	1	163	194	15	2009.2667
1143	loci	0.7913	0.3834	2	355	774	43	2009.4651
1144	locus	0.6354	0.5021	3	372	610	38	2007.0526
1145	locus ceruleus	0.0962	0.514	3	97	119	10	2002.6
1146	locus coeruleus	-0.0399	0.3745	3	227	325	28	2008.8929
1147	logistic regression	1.0644	0.3571	2	302	558	26	2011.6923
1148	logistic regression analysis	1.4512	-0.1315	2	225	394	18	2009.6111
1149	long term potentiation	-0.4869	-0.2984	1	392	698	59	2011.2542
1150	long term treatment	-0.2949	-0.5067	1	154	190	15	2011.0667
1151	longevity	-0.5268	-0.3834	1	129	152	16	2011.0625
1152	longitudinal change	1.3798	-0.0051	2	203	379	18	2012.2222
1153	longitudinal study	1.1773	-0.0524	2	555	1472	69	2009.6812
1154	low abeta42	1.3681	-0.2001	2	158	268	13	2010.4615
1155	low csf	1.4627	-0.1379	2	142	241	11	2007.7273
1156	low dose	-0.5234	-0.5226	1	114	133	12	2012.3333
1157	lower abeta	1.4743	-0.0118	2	118	204	10	2009.8
1158	lower csf	1.3044	-0.0393	2	178	276	12	2011.5
1159	lower csf abeta	1.419	0.1254	2	183	350	14	2011.1429
1160	lower level	0.5632	-0.1518	2	454	882	55	2010.9455
1161	lps	-0.332	-0.417	1	122	154	12	2010.8333
1162	lrp1	0.146	-0.2801	1	143	219	14	2009.5
1163	lrrk2	0.0246	0.3732	3	113	142	10	2010.5
1164	ltp	-0.5097	-0.2828	1	221	338	31	2010.8065
1165	lumbar puncture	1.3762	-0.0792	2	594	2006	93	2010.828
1166	lysine residue	-0.7628	0.3582	4	126	164	11	2004.6364
1167	lysosome	-0.56	-0.0338	1	219	318	30	2008.4
1168	m146l	-0.4761	-0.2075	1	80	103	10	2005.6
1169	m146v	-0.373	-0.3669	1	182	268	19	2008.8421
1170	mab	-0.7255	0.5108	4	355	716	45	1998.6
1171	magnetic resonance	0.5535	0.3495	4	299	458	25	2008.12
1172	magnetic resonance imaging	1.0452	0.0759	2	739	2506	120	2010.1833
1173	main component	-0.668	0.0806	4	374	606	55	2003.8364
1174	main outcome	1.344	0.008	2	317	724	25	2014.4
1175	main outcome measures	1.2122	0.0287	2	488	1270	52	2008.0962
1176	main risk factor	-0.4141	-0.5681	1	83	98	11	2011
1177	major depression	1.1704	-0.4273	2	114	198	12	2004.25
1178	major feature	-0.3656	-0.2866	1	89	102	10	2005.9
1179	major kinase	-0.7734	-0.3895	1	145	217	13	2009.3846
1180	major pathological hallmark	-0.7722	-0.1471	1	226	296	26	2009.1154
1181	major protein subunit	-1.1592	0.2455	4	161	367	18	1998.7222
1182	male	0.305	-0.0205	3	476	875	57	2009.2105
1183	malondialdehyde	-0.6875	-0.3721	1	189	284	18	2009.8889
1184	mammal	-0.5686	-0.1195	1	140	169	16	2011.0625
1185	mammalian brain	-0.8826	0.2008	4	188	254	17	2001.6471
1186	mammalian cell	-0.7302	0.0007	4	162	212	15	2005.4667
1187	mammalian target	-0.5267	-0.14	1	160	254	18	2012.1667
1188	man	0.593	0.0667	2	563	994	63	2008
1189	management	0.3316	-0.225	1	510	873	61	2011.1967
1190	map	-0.7996	0.332	4	860	2329	138	2002.7029
1191	map kinase	-1.1087	-0.0251	4	287	609	34	2000.0588
1192	map1	-1.1507	0.2186	4	138	355	16	2000.3125
1193	map2	-1.05	0.1954	4	428	1088	63	2002.0635
1194	mapk	-0.8763	-0.237	1	406	894	52	2005.1731
1195	mapks	-0.844	-0.2181	1	162	248	15	2005.1333
1196	mapt	0.5181	0.5001	3	591	1568	100	2010.96
1197	mapt gene	0.6615	0.5404	3	141	222	14	2011.5
1198	mapt locus	0.7808	0.5529	2	86	148	11	2009.1818
1199	mapt mutation	0.4197	0.5195	3	197	304	16	2010.3125
1200	march	1.3683	-0.1078	2	144	191	11	2012.4545
1201	mark	-0.9078	-0.0881	4	245	398	28	2008.3929
1202	mark2	-0.9154	-0.0853	4	121	218	13	2009.0769
1203	mass	-0.7544	0.3875	4	369	664	45	2000.6222
1204	maturation	-0.6495	0.1022	1	228	339	25	2004.76
1205	mature neuron	-0.81	-0.0787	1	167	218	15	2008.8
1206	mc1	-0.7941	0.1488	4	163	214	12	2009.3333
1207	mci	1.2554	-0.1574	2	1074	8142	395	2010.5696
1208	mci ad	1.5005	-0.18	2	239	525	23	2011.2174
1209	mci case	1.0655	-0.3454	2	141	226	10	2009.5
1210	mci group	1.2624	-0.1266	2	270	529	24	2009.9583
1211	mci patient	1.3689	-0.1672	2	527	2140	93	2010.6344
1212	mci subject	1.3036	-0.1956	2	314	683	31	2010.1613
1213	mean	0.8556	-0.1653	2	735	1779	102	2009.0686
1214	mean age	0.9608	0.1485	2	509	996	51	2007.6078
1215	mean level	1.3212	-0.2786	2	190	296	13	2005.6923
1216	measure	1.1136	-0.0085	2	1090	6008	297	2009.8788
1217	measurement	0.9932	-0.1961	2	1084	4843	255	2008.6196
1218	medial temporal lobe	0.682	0.3267	3	421	772	45	2010.2222
1219	medial temporal lobe atrophy	1.468	0.0439	2	214	410	17	2009.5294
1220	median	1.2516	-0.0502	2	292	520	24	2010
1221	medication	0.2874	-0.3388	1	339	554	40	2010.05
1222	melatonin	-0.6603	-0.4481	1	176	292	24	2009.5833
1223	memantine	-0.0077	-0.3936	1	449	836	59	2009.6949
1224	memory ability	-0.5538	-0.5254	1	146	210	15	2012.0667
1225	memory clinic	1.3892	-0.1063	2	483	1597	67	2011.3134
1226	memory complaint	1.1272	-0.0702	2	107	133	10	2010
1227	memory disturbance	0.2131	0.1737	3	209	253	14	2008.2143
1228	memory formation	-0.5255	-0.364	1	229	296	24	2011.5
1229	memory performance	0.4393	-0.2411	2	375	593	37	2011.1892
1230	memory test	0.3355	-0.312	1	176	246	14	2009.8571
1231	meta analysis	1.0639	0.2864	2	331	686	38	2011.1579
1232	metabolic syndrome	-0.3742	-0.5676	1	175	255	16	2012.625
1233	metal ion	-0.7511	0.1976	4	161	208	19	2007.2105
1234	methodology	0.4434	-0.1896	2	345	529	37	2008.9459
1235	methyl	0.6985	-0.0858	2	220	332	18	2011.0556
1236	meynert	-0.0923	0.35	3	261	369	27	2002.8889
1237	mg day	0.4362	-0.54	1	96	166	10	2007.6
1238	mg kg	-0.4957	-0.5158	1	336	631	44	2012.2955
1239	mice	-0.4515	-0.4089	1	361	519	42	2011.1429
1240	microgliosis	-0.3546	-0.3351	1	186	262	22	2011.3182
1241	microm	-1.028	-0.0306	4	352	592	38	2004.3421
1242	microtubule	-0.8524	0.1723	4	1668	12720	906	2003.7097
1243	microtubule affinity regulating kinase	-0.92	-0.0841	4	147	245	15	2008.1333
1244	microtubule assembly	-1.0309	0.1997	4	522	1383	85	2002.6353
1245	microtubule associated protein	-0.8903	0.1628	4	623	1621	106	2002.1604
1246	microtubule associated protein tau	-1.0319	0.3203	4	376	749	47	2000.383
1247	microtubule binding	-0.9877	0.2153	4	399	840	50	2003.54
1248	microtubule binding domain	-0.9153	0.3231	4	340	745	51	2002.6078
1249	microtubule binding protein	-0.7549	0.0357	1	184	233	20	2005.45
1250	microtubule binding protein tau	-0.7929	0.0307	4	110	124	12	2010.25
1251	microtubule binding region	-0.9851	0.4042	4	174	278	17	1999.7059
1252	microtubule binding repeat	-0.7186	0.3521	4	252	412	26	2005.7308
1253	microtubule destabilization	-0.8581	-0.1088	1	113	138	10	2011.2
1254	microtubule dynamic	-0.8989	-0.0034	4	187	281	22	2008.0909
1255	microtubule interaction	-0.9702	0.1926	4	181	302	17	2003.8824
1256	microtubule network	-0.9509	0.0289	4	275	496	31	2004.2581
1257	microtubule polymerization	-0.8737	0.0161	4	116	158	14	2010.6429
1258	microtubule stability	-0.8198	-0.0525	1	210	298	24	2008.875
1259	microtubule stabilization	-0.9445	0.1173	4	140	173	12	2009.8333
1260	middle	0.7695	0.0412	2	303	453	26	2009.7308
1261	mild ad	1.2812	-0.0908	2	378	816	37	2010.2432
1262	mild alzheimer	0.7942	-0.4966	2	188	307	17	2008.9412
1263	mild cognitive impairment	1.1436	-0.1553	2	1284	10761	539	2010.7254
1264	mild dementia	1.2347	0.0356	2	265	459	24	2006.7917
1265	mini mental state examination	1.1542	-0.0821	2	601	1852	89	2009.573
1266	mini mental state examination score	1.283	-0.011	2	412	903	43	2010.6047
1267	mini mental status examination	0.7556	-0.5002	2	147	210	10	2008.1
1268	mir	-0.6326	-0.4045	1	208	314	28	2013.7857
1269	misfolded protein	-0.5897	0.0118	4	316	475	42	2010.8095
1270	misfolding	-0.5982	0.0715	4	379	593	52	2012.1731
1271	missense mutation	-0.3442	0.5496	3	270	473	28	2003.5714
1272	mitochondria	-0.5748	-0.1732	1	511	986	88	2010.6932
1273	mitochondrial dysfunction	-0.517	-0.3232	1	484	883	97	2010.6082
1274	mitochondrial function	-0.4222	-0.3352	1	363	600	61	2011.0492
1275	mitochondrium	-0.5527	-0.1776	1	306	470	43	2010.1163
1276	mitogen	-0.8704	-0.2205	1	316	663	41	2004.4634
1277	mitogen activated protein	-1.1065	-0.0351	4	136	247	12	1998.8333
1278	mitogen activated protein kinase	-0.8868	-0.2103	1	295	580	36	2003.5556
1279	mitosis	-0.9326	-0.0136	4	225	328	20	2003.8
1280	mixed dementia	0.7776	0.1552	2	175	261	16	2010.5625
1281	mixture	-0.7093	0.3258	4	327	461	32	2004.5625
1282	mmse	1.2022	-0.126	2	612	1970	97	2009.5155
1283	mmse score	1.2059	-0.0908	2	450	1075	55	2008.4727
1284	mobility	-1.006	0.4179	4	232	447	27	1998.3333
1285	modality	0.8565	-0.0493	2	332	618	30	2011.1333
1286	moderate ad	0.6669	-0.5029	2	213	337	17	2010.7647
1287	modulate	-0.6706	-0.1516	1	228	322	22	2010.0455
1288	mol	-1.0794	0.2674	4	170	284	16	2001.5625
1289	molecular analysis	-0.4939	0.4108	3	100	130	11	1998.6364
1290	molecular chaperone	-0.7089	-0.0164	4	156	233	20	2011.85
1291	molecular characterization	-0.1538	0.5662	3	133	158	11	2002.9091
1292	molecular imaging	0.7337	-0.0275	2	143	227	16	2012.5
1293	molecular layer	-0.2392	0.3273	3	216	296	25	2001.56
1294	molecular pathway	-0.5456	-0.1565	1	168	208	23	2011.6957
1295	molecular target	-0.0525	-0.3385	1	151	183	20	2009.25
1296	molecular weight	-0.7931	0.4605	4	387	689	48	1998.6875
1297	monitoring	0.8181	-0.2549	2	375	661	43	2010.5349
1298	monoclonal antibody	-0.6258	0.459	4	972	3632	243	1998.465
1299	monomer	-0.698	0.1688	4	425	733	54	2008.7407
1300	month old 3xtg ad mouse	-0.3717	-0.4151	1	130	179	16	2012
1301	month old mouse	-0.3975	-0.4415	1	183	232	19	2010.8421
1302	morphometry	1.0303	0.2341	2	384	876	41	2010.8293
1303	morris water maze	-0.4393	-0.4763	1	377	663	53	2011.5472
1304	morris water maze test	-0.4436	-0.5176	1	216	323	24	2012.5
1305	motif	-0.9824	0.1436	4	610	1649	99	2005.3333
1306	motor neuron	0.0752	0.3591	3	255	355	24	2008.9583
1307	motor neuron disease	0.2033	0.5008	3	233	382	25	2005.12
1308	motor protein	-0.762	-0.0156	4	95	141	13	2007.4615
1309	mouse brain	-0.6148	-0.2156	1	553	976	76	2009.7763
1310	mouse line	-0.3839	-0.3539	1	120	156	17	2009.7059
1311	mri	1.1096	0.1002	2	842	3754	179	2010.8324
1312	mri measure	1.3316	0.0777	2	184	381	14	2011
1313	mri scan	1.3746	0.1833	2	235	454	18	2010.6667
1314	msa	0.042	0.46	3	136	214	12	2006.75
1315	mta	1.4849	0.0416	2	140	247	10	2010.2
1316	mtor	-0.5263	-0.1423	1	237	402	28	2012.2857
1317	mts	-0.9296	0.0555	4	206	346	23	2008.4783
1318	multicenter study	1.3198	-0.2457	2	269	658	27	2009.7407
1319	multifactorial disease	0.7242	0.2101	2	98	111	12	2010.0833
1320	multiple ad	-0.8009	-0.4826	1	124	208	14	2012.5714
1321	multiple site	-1.0638	-0.1963	4	165	234	13	2007.4615
1322	multiple system atrophy	0.0985	0.4494	3	326	590	33	2008.5152
1323	multivariate analysis	1.4827	-0.098	2	168	247	13	2010.4615
1324	mum	-0.6261	-0.424	1	292	388	28	2013.0714
1325	murine model	-0.3641	-0.3734	1	232	300	29	2011.3103
1326	muscarinic receptor	-0.3134	-0.3455	1	130	188	19	2006.8421
1327	muscle	-0.2475	0.1126	3	196	305	27	2002.5556
1328	muscle fiber	-0.2445	0.1142	3	101	227	18	2002.4444
1329	mutant	-0.8713	0.0872	4	580	1317	89	2007.3371
1330	mutant amyloid precursor protein	-0.4547	-0.2673	1	173	218	19	2007.6316
1331	mutant app	-0.4569	-0.2609	1	168	224	19	2006.9474
1332	mutant human tau	-0.5616	-0.0501	1	139	176	17	2011.8235
1333	mutant mouse	-0.4359	-0.1546	1	218	298	26	2009.2308
1334	mutant presenilin	-0.4574	-0.2642	1	111	143	15	2007.6667
1335	mutant protein	-0.6933	0.0325	4	113	136	12	2008.25
1336	mutant tau	-0.5909	-0.0869	1	237	350	29	2009.3448
1337	mutation carrier	1.0038	0.2079	2	283	537	23	2011.087
1338	mwm	-0.4358	-0.4789	1	132	173	14	2011.4286
1339	myoclonus	0.3614	0.4599	3	177	265	16	2006.0625
1340	n methyl	-0.6523	-0.2782	1	137	174	13	2010.9231
1341	n methyl d aspartate	-0.2601	-0.3308	1	163	219	16	2008.625
1342	n methyl d aspartate receptor	-0.5464	-0.2857	1	165	218	15	2008.3333
1343	n terminal	-0.7919	0.2579	4	323	506	33	2006.2727
1344	n terminal domain	-0.976	0.1813	4	149	190	12	2007.8333
1345	n terminal region	-0.1484	-0.2539	4	97	186	16	2006
1346	n terminus	-0.825	0.2844	4	374	627	36	2004.3611
1347	n2a	-0.9015	-0.3365	1	106	145	10	2010.6
1348	n2a cell	-0.896	-0.3358	1	219	426	28	2009.5357
1349	nachr	-0.4079	-0.3916	1	155	230	18	2011.2778
1350	nad	0.9575	-0.2531	2	204	333	19	2007.0526
1351	nap	-0.6494	-0.1846	1	67	87	10	2007.6
1352	national institute	0.9914	0.0288	2	434	980	44	2010.1136
1353	natural history	0.459	-0.056	2	165	197	15	2008.7333
1354	natural product	-0.2898	-0.4434	1	111	145	15	2012.4
1355	nci	0.2186	-0.0702	2	141	218	14	2010.4286
1356	ndc	0.4091	-0.0731	2	104	166	11	2010.2727
1357	ndd	1.0301	-0.41	2	120	209	12	2011.5
1358	near future	0.106	-0.3318	1	229	307	25	2009.84
1359	negative correlation	0.9868	0.0717	2	352	641	36	2009.9722
1360	negative inclusion	0.3185	0.5091	3	125	217	14	2006.7857
1361	negative predictive value	1.365	-0.2329	2	174	319	12	2009.25
1362	nerve cell	-0.5413	0.3493	3	404	709	52	2002.0962
1363	neurite	-0.3946	0.4156	3	798	2354	176	1998.9602
1364	neurite outgrowth	-0.8208	-0.148	1	391	649	45	2005.2444
1365	neuritic change	-0.0695	0.3747	3	182	233	18	1999.5556
1366	neuritic degeneration	-0.1524	0.319	3	165	203	17	2001.9412
1367	neuritic pathology	-0.2127	0.3331	3	155	204	17	2004.2353
1368	neuroblastoma cell	-0.8228	-0.1966	1	453	847	61	2006.2295
1369	neuroblastoma cell line	-0.7507	-0.1992	1	231	319	23	2007.6522
1370	neurochemical dementia diagnostic	1.0323	-0.411	2	100	189	11	2011.2727
1371	neurodegenerative cascade	-0.4154	-0.0256	1	135	164	14	2008.7857
1372	neurodegenerative dementia	0.5207	0.2904	3	241	360	21	2010.2857
1373	neurodegenerative tauopathy	-0.6066	0.221	4	286	448	33	2011.1212
1374	neurofibrillary change	-0.2458	0.4377	3	446	900	70	2000.5429
1375	neurofibrillary degeneration	-0.5562	0.3654	4	901	2756	198	2002.0657
1376	neurofibrillary lesion	-0.53	0.506	4	473	981	75	2001.12
1377	neurofilament	-0.5304	0.478	3	643	1754	129	1997.5969
1378	neurofilament protein	-0.5592	0.5106	4	375	747	49	1997.8367
1379	neurogenesis	-0.4784	-0.3597	1	392	671	62	2010.7258
1380	neuroimaging	0.847	0.0466	2	479	1028	57	2009.5614
1381	neuroimaging biomarker	1.0299	-0.0604	2	135	197	12	2013.25
1382	neuroimaging study	0.4615	0.2608	3	148	173	12	2010.0833
1383	neurological disease	0.488	0.1072	2	526	1044	66	2005.8636
1384	neurologist	0.5821	0.1146	3	131	169	10	2011.3
1385	neuronal apoptosis	-0.6318	-0.2902	1	390	708	51	2007.451
1386	neuronal cell	-0.7365	-0.2297	1	663	1437	113	2006.8407
1387	neuronal cell body	-0.465	0.4447	3	261	422	30	1999.7
1388	neuronal culture	-0.681	-0.2793	1	174	228	18	2009.5556
1389	neuronal cytoplasm	-0.4684	0.2393	3	188	250	22	2005
1390	neuronal cytoskeleton	-0.4993	0.2977	3	239	364	24	1998
1391	neuronal development	-0.7162	-0.1323	1	155	192	16	2007.9375
1392	neuronal differentiation	-0.8362	-0.0935	1	184	261	17	2007.5294
1393	neuronal expression	-0.5957	-0.0067	1	114	133	12	2005.5833
1394	neuronal inclusion	0.0327	0.5013	3	283	495	30	2002.7667
1395	neuronal injury	1.1039	-0.0259	2	379	619	33	2009.1515
1396	neuronal membrane	-0.5279	-0.2587	1	75	84	11	2010.6364
1397	neuronal microtubule	-0.9531	0.1839	4	294	512	33	2003.0606
1398	neuronal morphology	-0.7366	-0.2092	1	127	152	11	2006.9091
1399	neuronal perikarya	-0.4031	0.4363	3	234	339	25	1998.16
1400	neuronal plasticity	-0.6028	-0.3195	1	208	280	19	2007.9474
1401	neuronal population	-0.3795	0.2545	3	285	434	34	2002.1176
1402	neuronal process	-0.3922	0.2846	3	315	484	39	2004.5385
1403	neuronal soma	-0.6302	0.1063	4	153	182	13	2003.6923
1404	neuronal survival	-0.5622	-0.1487	1	180	248	20	2009.6
1405	neuronal tau protein	-1.0098	0.1738	4	82	114	11	2010.2727
1406	neuronal viability	-0.4697	-0.1938	1	149	181	16	2010.375
1407	neuropathologic	0.3857	0.4456	3	186	217	12	2005.9167
1408	neuropathologic feature	0.4247	0.3536	3	173	220	16	2006.625
1409	neuropathologic finding	0.4441	0.4513	3	150	196	14	2007.4286
1410	neuropathological diagnosis	0.3938	0.5509	3	186	257	18	2003
1411	neuropathological examination	0.2966	0.4402	3	316	469	34	2006.0588
1412	neuropathological finding	0.3267	0.4393	3	236	321	21	2005.0952
1413	neuropil	-0.2666	0.4308	3	345	594	47	2001.0851
1414	neuropil thread	-0.3262	0.4742	3	853	2663	187	2001.4545
1415	neuroplasticity	-0.4682	-0.3822	1	116	141	14	2009.7857
1416	neuroprotection	-0.5096	-0.3991	1	576	1082	93	2010.6344
1417	neuroprotective effect	-0.5169	-0.4571	1	595	1287	96	2011.0833
1418	neuroprotective property	-0.4003	-0.4693	1	178	225	18	2011.4444
1419	neuropsychiatric symptom	0.2265	-0.2146	1	209	278	19	2011.4737
1420	neuropsychological assessment	1.1377	0.0788	2	266	474	21	2012.0476
1421	neuropsychological evaluation	1.1694	-0.1222	2	147	214	10	2009.7
1422	neuropsychological test	1.1205	-0.0495	2	332	667	29	2010.1724
1423	neuropsychological testing	0.8115	0.1707	2	273	405	22	2009.4091
1424	neurotoxic effect	-0.4314	-0.2902	1	287	404	32	2007.875
1425	neurotoxicity	-0.5993	-0.2789	1	888	2223	192	2009.7656
1426	neurotoxin	-0.5469	-0.2525	1	217	276	22	2009.8182
1427	neurotrophin	-0.3325	-0.3064	1	137	169	16	2009.75
1428	new biomarker	0.9557	-0.3651	2	180	308	22	2011.5455
1429	new criterium	0.7155	-0.0126	2	107	187	11	2012.8182
1430	new diagnostic criterium	0.825	-0.2012	2	184	332	17	2012.9412
1431	new drug	-0.0004	-0.3801	1	159	205	16	2009.5
1432	new model	-0.6122	-0.2592	1	114	131	12	2011.3333
1433	new strategy	-0.032	-0.3001	1	144	201	16	2007
1434	new target	-0.1304	-0.3341	1	179	204	20	2011.25
1435	new therapeutic approach	-0.3198	-0.1295	1	126	142	16	2010.25
1436	new treatment	0.7714	-0.2731	2	169	216	11	2009.5455
1437	nfl	1.0203	0.2577	2	159	258	15	2008.4667
1438	nft formation	-0.5465	0.1898	4	538	1064	79	2004
1439	ng l	1.4498	-0.1979	2	157	272	12	2010.25
1440	ng ml	0.8031	-0.4654	2	236	356	19	2007.6316
1441	nicotinic acetylcholine receptor	-0.4087	-0.3887	1	158	211	18	2010.9444
1442	nitration	-0.8415	0.1559	4	194	287	18	2007.5
1443	nitric oxide	-0.3585	-0.2644	1	201	270	25	2008.12
1444	nitric oxide synthase	-0.3555	-0.2629	1	150	182	16	2006.875
1445	nmda	-0.2943	-0.3291	1	257	410	28	2010.3214
1446	nmda receptor	-0.4864	-0.3082	1	194	294	25	2010.6
1447	nmdar	-0.539	-0.2912	1	140	195	13	2012.6923
1448	nmr	-0.972	0.2137	4	199	364	27	2008.3704
1449	nmr spectroscopy	-0.9936	0.2282	4	136	247	16	2008.1875
1450	non ad	1.2398	-0.2681	2	263	479	25	2008.6
1451	non ad dementia	1.3093	-0.3324	2	195	360	16	2008.75
1452	non ad dementias	1.3145	-0.3156	2	242	454	20	2008.35
1453	non ad patient	1.3981	-0.2975	2	196	364	19	2008.1579
1454	non alzheimer	0.5762	0.2782	3	254	397	25	2002.96
1455	non carrier	1.1068	0.2579	2	319	604	27	2011.7037
1456	non demented subject	0.3073	0.3086	3	163	197	14	2004.7143
1457	non neuronal cell	-0.7304	-0.0747	1	141	177	15	2007.4667
1458	non steroidal anti inflammatory drug	-0.2217	-0.4028	1	102	125	10	2008.4
1459	non tg	-0.3865	-0.4238	1	123	156	13	2011.2308
1460	non transgenic mouse	-0.3684	-0.4191	1	130	163	12	2009.4167
1461	noncarrier	1.3136	0.1028	2	284	536	21	2011.4762
1462	nondemented control	0.6545	0.354	2	287	452	33	2003.6364
1463	nonsteroidal anti inflammatory drug	-0.1747	-0.409	1	123	147	11	2005.8182
1464	nontransgenic mouse	-0.3726	-0.4388	1	101	118	11	2010.4545
1465	normal aged brain	-0.5737	0.4724	4	105	133	11	1994.4545
1466	normal ageing	0.8296	-0.1138	2	232	344	23	2006.9565
1467	normal brain	-0.8399	0.3834	4	454	848	54	2000.6667
1468	normal cognition	1.2569	0.118	2	311	651	34	2012.0294
1469	normal control	1.1043	0.0196	2	736	2014	112	2006.4821
1470	normal control subject	1.0737	0.0034	2	281	559	26	2003.4231
1471	normal human brain	-0.8858	0.502	4	213	334	21	1997.8095
1472	normal human tau	-0.8301	0.5174	4	138	223	11	1996.4545
1473	normal individual	1.2353	0.1149	2	366	728	40	2010.5
1474	normal level	0.3522	-0.178	2	177	243	16	2005.0625
1475	normal older adult	1.4229	0.046	2	164	256	12	2012.3333
1476	normal pressure hydrocephalus	1.0274	-0.1003	2	238	372	22	2008.4091
1477	normal protein	-0.282	0.1439	4	71	87	10	2006.2
1478	normal subject	1.162	0.1982	2	377	734	37	2009.1622
1479	normal tau	-1.0277	0.3575	4	518	1510	83	1999.7831
1480	normal tau protein	-0.5827	0.6147	4	173	256	15	1995.0667
1481	novel biomarker	0.8796	-0.3382	2	252	446	25	2011.48
1482	novel mechanism	-0.8894	-0.1151	1	240	358	27	2010.1111
1483	novel object recognition	-0.483	-0.4738	1	107	129	10	2013.7
1484	novel object recognition test	-0.3702	-0.4728	1	133	164	12	2013.1667
1485	novel pathway	-0.6569	-0.1397	1	122	134	11	2008.7273
1486	novel role	-0.6775	-0.2679	1	116	142	11	2012.3636
1487	novel therapeutic approach	-0.2904	-0.3401	1	147	174	17	2010.8824
1488	novel therapeutic strategy	-0.2626	-0.3641	1	146	179	19	2009.1053
1489	novel therapeutic target	-0.5516	-0.3051	1	168	204	20	2011.15
1490	novel therapy	-0.006	-0.2897	1	111	120	13	2010.1538
1491	novel treatment	-0.3113	-0.5082	1	123	147	13	2010.7692
1492	nsaid	-0.1745	-0.4061	1	130	178	12	2006.5
1493	nsaids	-0.1791	-0.4076	1	138	203	15	2006.9333
1494	ntr	-0.4345	-0.1912	1	100	123	10	2008.4
1495	nts	-0.346	0.4346	3	112	150	13	2003.9231
1496	nucleation	-0.927	0.2512	4	196	354	22	2004.8182
1497	nuclei	-0.1802	0.3557	3	593	1112	77	2003.9351
1498	nucleus	-0.2856	0.2912	3	586	1079	80	2006.1875
1499	numbering	-1.0307	0.4221	4	126	193	12	1998.1667
1500	numerous neurodegenerative disorder	-0.2184	0.3635	3	106	127	11	2005.9091
1501	o glcnacylation	-0.9435	-0.1387	4	128	221	18	2010.3889
1502	obesity	-0.4229	-0.5558	1	292	505	38	2012.5789
1503	object	0.0144	-0.488	1	159	192	16	2009.625
1504	occipital cortex	0.3982	0.3819	3	161	192	13	2006.3077
1505	odds ratio	1.0444	0.3778	2	333	786	43	2010.0233
1506	okadaic acid	-0.9648	-0.2549	1	425	1068	68	2006.25
1507	older adult	1.3054	0.0281	2	298	568	28	2012.6786
1508	older age	0.8037	0.1307	2	285	414	22	2011.2273
1509	older individual	1.1887	0.0358	2	220	379	22	2011.1818
1510	older patient	0.4348	0.0822	3	179	212	13	2005.7692
1511	older person	0.3411	0.0116	2	228	336	23	2008.8696
1512	olfactory bulb	0.1322	0.3894	3	139	197	19	2006.7895
1513	olfactory epithelium	-0.4071	0.5269	3	103	139	12	2000.0833
1514	oligodendrocyte	-0.0884	0.5039	3	248	390	26	2004.2308
1515	oligomeric abeta	-0.4971	-0.3069	1	192	232	22	2011.1364
1516	oligomerization	-0.7494	0.0038	4	435	681	55	2011.0182
1517	ond	1.3759	-0.2916	2	130	209	10	2006.9
1518	open field	-0.3399	-0.4464	1	103	133	10	2011.6
1519	oral administration	-0.3964	-0.4596	1	178	242	19	2010.7368
1520	organelle	-0.597	-0.0389	1	304	498	39	2007.7436
1521	organism	-0.6364	-0.1282	1	183	240	24	2009.75
1522	outcome	0.3616	-0.4042	1	799	1801	115	2011.0435
1523	outcome measure	0.8598	-0.3677	2	352	781	34	2010.8824
1524	overactivation	-0.7936	-0.4477	1	225	365	22	2007.4545
1525	overexpression	-0.6447	-0.199	1	746	1735	142	2008.0986
1526	overlap	0.382	0.3583	3	537	1030	68	2006.6471
1527	oxidation	-0.6037	-0.1243	1	391	644	57	2007.2105
1528	oxidative injury	-0.5603	-0.3701	1	118	156	12	2006
1529	p tau	1.2744	-0.1881	2	1112	6085	302	2011.0232
1530	p tau concentration	1.4102	-0.0778	2	173	273	13	2011.4615
1531	p tau level	1.3739	-0.0555	2	245	427	23	2011.8261
1532	p tau181	1.3306	-0.0971	2	405	1020	43	2011.5814
1533	p tau181p	1.4547	-0.2387	2	197	361	15	2012.8
1534	p value	0.9551	0.4055	2	187	298	16	2011
1535	p00001	1.0723	-0.3088	2	217	340	17	2008.8235
1536	p0001	1.1786	-0.1004	2	401	849	44	2008.6364
1537	p001	1.1751	-0.0867	2	357	674	35	2007.4286
1538	p002	1.1593	-0.1379	2	140	185	11	2010.0909
1539	p005	1.211	-0.1078	2	287	539	28	2010.4286
1540	p25	-0.9053	-0.3089	1	222	438	27	2007.3704
1541	p301l	-0.4748	-0.1521	1	509	991	65	2008.9846
1542	p301l mutation	-0.5071	0.1101	1	178	229	15	2009.9333
1543	p301l tau	-0.5529	-0.0813	1	149	175	13	2012.7692
1544	p35	-0.8726	-0.3223	1	163	271	17	2006.7059
1545	p38	-0.6492	-0.3789	1	232	404	21	2006.2381
1546	p53	-0.7461	-0.2883	1	186	291	22	2007.3636
1547	p62	-0.362	0.1658	3	166	217	15	2010.8
1548	paired helical filament	-0.87	0.3799	4	830	2740	193	1999.1399
1549	panel	0.5245	0.1008	2	741	1868	97	2006.3505
1550	par	-0.913	-0.0887	4	149	275	17	2008.7059
1551	paradigm shift	0.008	-0.3371	1	132	167	15	2010.6667
1552	paraffin	-0.2783	0.498	3	174	231	17	2004.2941
1553	paraffin section	-0.1703	0.4557	3	167	224	19	2000.1579
1554	parahippocampal gyrus	0.2641	0.5023	3	243	321	19	2002.4211
1555	parameter	0.4934	-0.2253	2	748	1749	107	2008.4579
1556	parietal	0.94	0.2025	2	444	988	49	2008.2653
1557	parietal lobe	0.3886	0.4198	3	244	307	16	2006.6875
1558	parkinsonism	0.0523	0.5035	3	828	2518	152	2006.5789
1559	parkinsonism dementia complex	-0.1227	0.5214	3	149	238	20	2001.6
1560	participant	1.2518	0.0718	2	914	4940	218	2011.7339
1561	participate	-0.4781	-0.0156	1	207	278	22	2007.1818
1562	particular emphasis	-0.0253	-0.3334	1	79	89	11	2011.7273
1563	passive immunization	-0.0115	-0.3543	1	240	383	30	2010.8667
1564	passive immunotherapy	0.0296	-0.3634	1	187	288	21	2011.7143
1565	past	0.0461	-0.2885	1	124	146	15	2010.6667
1566	pathobiology	0.2835	-0.0966	2	225	343	23	2007.087
1567	pathogenic factor	-0.4668	-0.2217	1	179	213	17	2009.6471
1568	pathogenic mutation	0.4596	0.4871	3	177	277	23	2007.3913
1569	pathogenic protein	-0.3135	0.1197	3	116	132	14	2011.0714
1570	pathologic process	0.4443	0.1175	2	198	238	15	2008.8667
1571	pathological	-0.4778	0.572	4	119	155	11	2003.3636
1572	pathological aggregation	-0.8862	0.1799	4	237	331	23	2008.2174
1573	pathological diagnosis	0.5076	0.4294	3	208	287	19	2005.6316
1574	pathological phosphorylation	-0.8775	-0.0891	1	157	210	12	2009.6667
1575	pathological tau	-0.5924	0.287	4	432	762	56	2007.125
1576	pathological tau protein	-0.241	0.5487	3	192	280	21	2004.3333
1577	pathophysiological process	0.6864	-0.199	2	214	325	22	2010.4545
1578	patient group	1.059	-0.1643	2	290	498	28	2008.0714
1579	pca	0.8179	0.2982	3	127	192	11	2011.1818
1580	pd case	0.6106	0.5513	3	139	190	15	2005.0667
1581	pd patient	0.823	0.2497	2	259	439	28	2010.2143
1582	pdd	0.7908	0.2763	3	245	424	26	2010.1538
1583	pedigree	0.3375	0.457	3	173	234	18	2003.9444
1584	peptide fragment	-0.8107	0.372	4	198	266	17	2000.1176
1585	peptidyl prolyl	-0.9934	-0.0034	4	159	295	20	2008.1
1586	percent	0.7066	0.07	2	279	398	26	2004.9615
1587	perforant pathway	-0.295	0.2069	3	122	144	15	2005.5333
1588	performance	0.611	-0.3792	2	932	3032	174	2010.3161
1589	perikarya	-0.4406	0.4296	3	242	422	29	1996.931
1590	peripheral insulin resistance	-0.4424	-0.5724	1	116	171	11	2012.5455
1591	perk	-0.716	-0.2591	1	129	195	12	2011.8333
1592	personality change	0.2434	0.4061	3	196	258	16	2005.625
1593	pet	0.8755	0.0237	2	773	2905	158	2011.2722
1594	pet imaging	0.8658	0.0115	2	325	613	40	2012.175
1595	pet tracer	0.5302	-0.0387	2	173	268	17	2013.6471
1596	pg ml	1.2963	-0.2333	2	577	2076	96	2007
1597	pgrn	0.4376	0.5101	3	143	216	14	2009.8571
1598	pharmacokinetic	-0.0454	-0.4261	1	138	207	13	2012.3846
1599	pharmacological agent	-0.2579	-0.5316	1	99	122	11	2010.0909
1600	pharmacological inhibition	-0.7563	-0.3158	1	158	227	16	2011.5625
1601	pharmacological intervention	0.033	-0.3373	1	165	201	18	2007.2778
1602	pharmacological treatment	0.0188	-0.3713	1	201	264	22	2008.8182
1603	pharmacology	-0.1361	-0.3419	1	157	215	16	2008.5
1604	pharmacotherapy	-0.0333	-0.3445	1	165	217	19	2008.4737
1605	phf	-0.8517	0.3992	4	1300	8261	536	1999.3955
1606	phf assembly	-0.9561	0.3237	4	123	207	13	1999.8462
1607	phf core	-0.9043	0.3875	4	124	226	13	1998.6923
1608	phf formation	-0.93	0.3102	4	236	441	27	2000.2963
1609	phf tau	-0.8662	0.4886	4	618	1938	119	1998.2353
1610	phf1	-0.8749	-0.1909	1	149	192	11	2007.6364
1611	phfs	-0.889	0.3736	4	555	1763	104	1998.5865
1612	phftau	-0.4146	0.6051	4	138	178	13	2001.8462
1613	phosphatase	-1.0185	-0.0677	4	759	2376	147	2004.2993
1614	phosphatase activity	-1.0404	-0.1432	4	361	796	49	2005.8367
1615	phosphatase treatment	-0.846	0.5365	4	150	267	13	1993.9231
1616	phosphate	-1.0706	0.2718	4	346	677	41	2000.6829
1617	phosphatidylinositol	-0.7916	-0.4939	1	224	416	25	2007.68
1618	phospho tau level	0.277	-0.4499	1	159	201	14	2010.6429
1619	phosphoepitope	-1.0087	0.0792	4	301	476	26	2003.5385
1620	phosphopeptide	-1.0936	0.3016	4	173	346	21	2002.7619
1621	phosphoprotein	-1.0234	0.2823	4	281	469	29	2000.5172
1622	phosphorylate	-0.9746	-0.0989	4	256	456	28	2002.7143
1623	phosphorylate tau	-0.9882	-0.1538	4	135	208	11	2004.1818
1624	phosphorylated epitope	-0.7726	0.561	4	236	478	29	1994.0345
1625	phosphorylated form	-0.6336	0.1456	4	418	697	47	2003.9787
1626	phosphorylated neurofilament	-0.4734	0.4599	3	124	175	14	1998.7143
1627	phosphorylated protein	-0.6155	0.0841	1	191	266	18	2001.1111
1628	phosphorylated site	-0.967	0.44	4	225	366	21	2000.2381
1629	phosphorylated tau level	0.6215	-0.0435	2	288	430	26	2010.8462
1630	phosphorylated tau181	1.3622	-0.0146	2	215	346	15	2012.5333
1631	phosphorylation	-0.8642	-0.1478	1	1756	15955	1129	2006.7263
1632	phosphorylation dependent antibody	-1.1402	0.2897	4	125	179	11	1998.0909
1633	phosphorylation event	-0.9877	-0.0401	4	182	271	17	2005.4118
1634	phosphorylation level	-0.7177	-0.4539	1	286	431	29	2011.7931
1635	phosphorylation site	-1.0767	0.1424	4	684	2236	124	2002.6855
1636	phosphorylation state	-0.9116	0.0548	4	461	872	64	2002.8906
1637	phosphorylation status	-0.931	-0.2113	1	235	355	24	2008.5417
1638	physiological condition	-0.915	0.1729	4	267	430	33	2007.0909
1639	physiological function	-0.9086	0.123	4	200	262	21	2009.9524
1640	physiological role	-0.8951	0.0722	4	174	238	20	2005.85
1641	pi3k	-0.781	-0.4929	1	179	327	17	2010.1176
1642	pib	1.0863	0.0881	2	442	1044	50	2011.34
1643	pib pet	0.9682	-0.0113	2	178	274	13	2011.7692
1644	picalm	1.0041	0.3341	2	156	307	12	2012.6667
1645	pick	-0.0665	0.5564	3	690	2092	123	2003.3252
1646	pick body	-0.0781	0.542	3	484	1118	63	2002.1111
1647	pick disease	-0.0524	0.5314	3	363	680	39	2006.7692
1648	pid	-0.2556	0.56	3	336	722	36	2004.8056
1649	pilot study	0.4995	-0.3887	2	243	354	22	2010.1364
1650	pin1	-1.0055	0.0004	4	334	915	59	2008.7797
1651	pin1 bind	-1.0435	0.0041	4	116	210	11	2004.8182
1652	pittsburgh compound b	1.1045	0.0743	2	483	1307	57	2012.1228
1653	pka	-1.1054	-0.1023	4	302	718	40	2004.2
1654	pkc	-0.8407	-0.3509	1	254	486	31	2005.1935
1655	placebo	0.4353	-0.5259	1	389	969	49	2010.0408
1656	placebo group	0.4738	-0.5345	1	145	302	13	2011.4615
1657	plant	-0.2882	-0.4497	1	76	89	11	2011.6364
1658	plaque neurite	-0.7456	0.6069	4	110	170	12	1993.75
1659	plasma	0.8316	-0.3987	2	721	2069	130	2010.1692
1660	plasma abeta	1.2344	-0.0729	2	214	352	14	2010.0714
1661	plasma biomarker	1.1362	-0.1332	2	194	303	14	2012.9286
1662	plasma level	0.5632	-0.5045	2	276	511	30	2010.6667
1663	plasma membrane	-0.6678	0.0141	4	210	277	20	2009.3
1664	platform	0.7541	-0.3884	2	432	875	48	2011.8125
1665	play	-0.6853	-0.157	1	247	367	35	2009.8857
1666	pnfa	0.5763	0.5019	3	129	210	10	2010.4
1667	point mutation	-0.7571	0.1771	4	209	278	20	2004.75
1668	polyanion	-0.9598	0.2638	4	121	178	11	2003.3636
1669	polyclonal antibody	-0.6618	0.5304	4	312	574	39	1995.5897
1670	polymer	-0.8571	0.3255	4	307	565	44	2001.6818
1671	polymerization	-0.9146	0.2329	4	441	971	65	2003.3692
1672	polymorphism	0.7648	0.4879	2	666	2088	156	2006.9167
1673	polypeptide	-0.8142	0.5149	4	417	923	55	1998.6545
1674	polyphenol	-0.5304	-0.4186	1	177	213	20	2012.2
1675	positive association	1.0403	0.189	2	205	287	13	2011.5385
1676	positive cell	-0.3616	-0.0057	1	210	290	25	2007.48
1677	positive correlation	0.8872	0.0382	2	409	790	50	2008.06
1678	positive effect	-0.1426	-0.4866	1	121	149	13	2012.3077
1679	positive inclusion	0.2242	0.4898	3	241	375	24	2008.125
1680	positive neurofibrillary tangle	-0.219	0.4764	3	167	228	17	2003.8824
1681	positive neuron	-0.304	0.3117	3	327	532	43	2003
1682	positive predictive value	1.3659	-0.2262	2	191	338	13	2007.0769
1683	positive result	0.2327	-0.2654	1	176	233	13	2009
1684	positivity	0.5964	0.2154	3	379	641	35	2006.8
1685	positron emission tomography	0.9456	0.0476	2	745	2820	138	2010.6957
1686	possession	1.0153	0.3578	2	142	197	12	2003.0833
1687	possible biomarker	0.9801	-0.1024	2	118	151	10	2010.4
1688	possible implication	-0.6001	-0.1457	1	159	189	16	2007.9375
1689	post translational modification	-0.8143	0.1341	4	493	930	74	2008.5541
1690	posterior cingulate	1.057	0.161	2	261	474	21	2011.6667
1691	posterior cingulate gyrus	1.0729	0.1834	2	125	168	10	2011.3
1692	posterior cortical atrophy	0.8166	0.2996	3	159	261	15	2012.2
1693	postmortem examination	0.3941	0.3382	3	174	209	14	2007.7857
1694	postmortem study	0.724	0.132	2	152	188	12	2007.8333
1695	posttranslational modification	-0.8251	0.1863	4	297	503	40	2006.25
1696	potent inhibitor	-0.881	-0.2872	1	140	183	15	2008.5333
1697	potential association	0.0813	-0.5923	1	144	173	11	2013.6364
1698	potential benefit	-0.3328	-0.5201	1	119	140	10	2009.8
1699	potential biomarker	0.9753	-0.3267	2	262	482	32	2010.375
1700	potential disease	0.0202	-0.4158	1	152	181	13	2009.3077
1701	potential marker	1.2454	0.2245	2	110	151	11	2005.4545
1702	potential therapeutic agent	-0.7216	-0.2225	1	151	185	16	2010.875
1703	potential therapeutic approach	-0.3596	-0.4997	1	101	123	12	2011.5833
1704	potential therapeutic strategy	-0.4327	-0.2212	1	86	92	11	2011.4545
1705	potential therapeutic target	-0.6552	-0.2941	1	231	322	32	2011.5312
1706	potential treatment	-0.2886	-0.3893	1	212	262	27	2010.1481
1707	potential use	-0.3995	-0.5607	1	200	263	19	2010.6316
1708	potential usefulness	1.0095	-0.1158	2	173	228	12	2009.3333
1709	power	1.2815	-0.0554	2	518	1360	66	2010.0303
1710	powerful tool	0.7554	-0.2122	2	105	131	11	2012.1818
1711	pp 2a	-1.1274	-0.0887	4	239	536	27	2004.2222
1712	pp1	-1.0281	-0.1771	4	158	242	15	2008.2
1713	pp2a	-0.9892	-0.2471	1	514	1507	94	2009.3191
1714	pp2a activity	-0.996	-0.2647	1	264	581	36	2009.5833
1715	pp2ac	-0.9432	-0.2885	1	121	223	13	2011.6923
1716	pp2b	-1.0862	-0.1358	4	134	222	13	2004.6923
1717	ppa	0.5589	0.5005	3	147	233	14	2008.8571
1718	preclinical ad	1.1719	-0.0226	2	307	681	35	2011.9143
1719	preclinical alzheimer	1.0147	-0.0545	2	225	331	20	2010.25
1720	preclinical alzheimer disease	1.3106	0.0621	2	189	282	12	2013.0833
1721	preclinical model	-0.2967	-0.222	1	86	90	11	2013.6364
1722	preclinical phase	1.0545	-0.0702	2	245	385	22	2009.7727
1723	preclinical stage	0.9763	-0.1225	2	401	820	41	2011.6585
1724	preclinical study	-0.1373	-0.3597	1	237	322	29	2011.9655
1725	precuneus	1.1361	0.1346	2	289	503	21	2012.7619
1726	prediction	1.2286	-0.2057	2	577	1893	95	2010.0947
1727	predictive value	1.3127	-0.1565	2	342	730	34	2010.5
1728	predictor	1.302	-0.0689	2	643	2205	105	2009.9238
1729	predominance	0.004	0.5898	3	183	252	17	2006.5882
1730	preparation	-0.8081	0.4072	4	587	1276	89	2000.7303
1731	presenile dementia	0.2057	0.5565	3	180	263	17	2004.4118
1732	presentation	0.5327	0.3737	3	428	734	47	2008.5532
1733	presymptomatic stage	0.6807	-0.2934	2	165	212	11	2011.2727
1734	pretangle	-0.3107	0.4083	3	281	424	32	2007.9375
1735	pretangle neuron	-0.4782	0.357	3	176	266	17	2004
1736	pretreatment	-0.7444	-0.1527	1	411	714	47	2005.0851
1737	prevalent form	0.0008	-0.3509	1	114	131	12	2012.6667
1738	primary cortical neuron	-0.819	-0.2994	1	177	244	18	2009.1667
1739	primary culture	-0.7831	-0.1989	1	287	446	27	2006.1111
1740	primary event	-0.4164	-0.22	1	113	125	15	2004.6667
1741	primary neuron	-0.7512	-0.1757	1	434	770	56	2011.25
1742	primary neuronal culture	-0.7202	-0.3106	1	193	257	18	2007.3333
1743	primary progressive aphasia	0.5576	0.4931	3	316	622	35	2009.4857
1744	principal component	-0.9276	0.375	4	188	273	16	1999.9375
1745	prion	-0.4542	0.1359	4	319	542	56	2011.8929
1746	prion disease	0.0171	0.2084	3	290	492	46	2009.2826
1747	prnp	0.4176	0.3991	3	142	177	13	2010.0769
1748	pro	-1.0384	0.0809	4	266	484	26	2002.9615
1749	pro inflammatory cytokine	-0.4716	-0.4162	1	107	119	13	2012.3077
1750	probability	0.7975	0.1952	2	210	286	18	2009.2222
1751	probable ad	1.1355	-0.232	2	530	1305	63	2006.3968
1752	probable alzheimer	0.9784	0.1755	2	289	480	26	2006.1538
1753	proband	0.2803	0.534	3	196	325	21	2007.3333
1754	procedure	0.4658	-0.1257	2	742	1841	112	2005.6071
1755	prodromal	0.9354	-0.0095	2	157	210	12	2011.1667
1756	prodromal ad	1.1685	-0.1861	2	264	470	19	2012.4211
1757	prodromal alzheimer	1.2494	-0.2156	2	196	321	15	2012.1333
1758	prodromal phase	1.4399	-0.242	2	145	229	11	2012.1818
1759	prodromal stage	0.8495	-0.2189	2	239	359	17	2011.5294
1760	prognosis	1.2826	-0.2097	2	327	678	38	2011.7105
1761	prognostic value	1.2384	-0.1808	2	177	263	11	2010.7273
1762	program	0.5337	-0.2206	2	383	732	45	2009.6
1763	progranulin	0.468	0.5082	3	232	461	27	2011.0741
1764	progressive aphasia	0.435	0.5262	3	167	257	14	2006.5
1765	progressive degeneration	-0.3785	-0.0592	1	101	113	10	2004.2
1766	progressive impairment	-0.3564	-0.4954	1	105	112	10	2009.2
1767	progressive neurodegeneration	-0.418	-0.5342	1	154	183	18	2008.6111
1768	progressive supranuclear palsy	-0.0037	0.5454	3	1053	4252	258	2004.5233
1769	proline	-1.0831	0.0786	4	485	1434	82	2001.9756
1770	promising biomarker	1.0057	-0.1639	2	152	223	11	2009.8182
1771	promising candidate	-0.099	-0.4721	1	206	253	15	2012
1772	promising result	-0.0598	-0.3831	1	189	231	21	2010.4762
1773	promising target	-0.5877	-0.4539	1	104	115	10	2013.1
1774	promising therapeutic target	-0.8476	-0.1371	1	163	228	17	2010.7647
1775	promote	-0.872	-0.1274	1	233	335	23	2009.7826
1776	promoter region	0.6552	0.5344	2	107	163	13	2009.9231
1777	promotion	-0.7762	-0.0586	4	211	268	18	2009.5
1778	pronase	-0.9028	0.4261	4	90	152	10	1991.9
1779	propensity	-0.8588	0.2154	4	280	432	32	2008.5625
1780	prospective study	1.0622	-0.1342	2	292	492	29	2006.5172
1781	protease	-0.6512	0.0526	4	508	901	73	2006.2466
1782	proteasome	-0.7007	0.0358	4	119	151	14	2008.2857
1783	protective effect	-0.5059	-0.4518	1	494	891	68	2010.5147
1784	protein concentration	0.948	-0.3969	2	306	582	38	2006.0526
1785	protein hyperphosphorylation	-0.5649	-0.4438	1	162	215	19	2010.6316
1786	protein kinase	-0.9932	-0.1284	4	900	3573	223	2004.1525
1787	protein kinase b	-0.7501	-0.5391	1	187	346	20	2008.95
1788	protein kinase c	-0.8357	-0.3133	1	298	514	34	2003.9118
1789	protein misfolding	-0.5783	0.0409	4	299	452	39	2011.641
1790	protein misfolding disease	-0.4558	0.1163	4	84	110	11	2011.3636
1791	protein phosphatase	-1.0129	-0.1837	4	788	3186	192	2007.1406
1792	protein phosphorylation	-0.6935	-0.3281	1	545	1047	77	2007.6494
1793	protein protein interaction	-0.7123	0.0254	4	130	169	14	2008.2857
1794	protein tau	-0.7042	0.2563	4	1476	6859	479	2004.1608
1795	proteinopathy	0.3492	0.4179	3	232	399	31	2011.4839
1796	proteolysis	-0.7688	0.2	4	604	1334	99	2002.7172
1797	proteolytic cleavage	-0.7744	0.0559	4	263	378	28	2006.4286
1798	proteolytic fragment	-0.4622	-0.2033	1	126	138	12	2005.6667
1799	proteolytic processing	-0.5352	-0.2374	1	155	188	16	2008.1875
1800	ps1	-0.4032	-0.2627	1	603	1232	100	2007.83
1801	ps2	-0.1545	-0.2098	1	247	371	31	2007.3871
1802	ps422	-0.716	0.1285	4	138	185	12	2011
1803	psd	-0.5617	-0.2878	1	182	221	18	2012.6667
1804	psen1	0.5595	0.44	3	431	806	52	2011.2308
1805	psen2	0.5744	0.4517	3	216	374	25	2011.72
1806	pseudophosphorylation	-0.9525	0.1701	4	129	191	11	2008.5455
1807	psp	-0.0414	0.5614	3	711	1987	122	2003.1967
1808	psp case	-0.1688	0.4961	3	114	173	15	2000.3333
1809	psychiatric disorder	1.3052	-0.3166	2	196	287	14	2007.6429
1810	psychological symptom	0.2583	-0.2251	1	165	209	13	2009.9231
1811	psychosis	0.335	0.2887	3	151	189	15	2008.4
1812	ptau	1.1479	0.0172	2	569	1363	78	2011.2436
1813	ptau181	1.4012	-0.0202	2	157	262	13	2011.7692
1814	publication	0.6738	-0.1558	2	245	349	24	2010.625
1815	purification	-0.7792	0.3567	4	198	271	22	2002.8636
1816	pyramidal cell	-0.3991	0.353	3	266	426	35	2004.2571
1817	pyramidal neuron	-0.4401	0.2563	3	510	998	77	2002.2987
1818	quality	0.4165	-0.2537	2	312	448	35	2010.2
1819	quantification	0.5256	0.0159	2	576	1288	83	2008.3855
1820	quantitation	0.1905	0.1875	2	180	238	18	2003.3889
1821	r406w	-0.5891	0.377	4	190	309	16	2005.8125
1822	r406w mutation	0.1797	0.5581	3	149	222	12	2007.25
1823	rabbit	-0.393	-0.0411	1	235	364	28	2003.7143
1824	radiotracer	0.5904	-0.0441	2	187	330	22	2012.6818
1825	rage	-0.328	-0.3475	1	164	241	19	2010.7368
1826	random coil	-0.9288	0.2733	4	107	200	11	2005.7273
1827	rapamycin	-0.5245	-0.1396	1	207	321	23	2012.1304
1828	rapid progression	1.2907	0.0643	2	155	214	11	2009.0909
1829	rat	-0.5901	-0.4789	1	936	2984	229	2008.441
1830	rat brain	-0.9024	-0.2898	1	472	973	63	2004.1587
1831	rat hippocampal neuron	-0.7536	-0.263	1	133	175	14	2005.5
1832	rat hippocampus	-0.7165	-0.3891	1	135	186	14	2005.5
1833	rat model	-0.5012	-0.5395	1	409	827	63	2011.6984
1834	rate	0.6807	-0.0262	2	1306	4935	272	2009.0331
1835	ratio	0.879	-0.2636	2	1364	6208	339	2009.6608
1836	react	-0.8334	0.5304	4	159	268	16	1995.1875
1837	reactivation	-0.8089	-0.0941	1	141	204	14	2005.1429
1838	reactive	-0.7735	0.4939	4	277	451	26	1999.1154
1839	reactive astrocyte	-0.368	0.1817	3	339	522	38	2005.3947
1840	reactive oxygen species	-0.5708	-0.3209	1	432	732	67	2010.3134
1841	reactivity	-0.775	0.4619	4	598	1332	83	2000.747
1842	receiver	1.4131	-0.1198	2	319	758	28	2010.75
1843	receiver operating characteristic	1.4372	-0.2631	2	147	243	10	2009.3
1844	recent discovery	0.0552	0.3473	3	122	168	13	2004.2308
1845	recent findings	0.5403	-0.0703	2	132	157	13	2010.9231
1846	receptor agonist	-0.3989	-0.5466	1	199	286	20	2010.15
1847	receptor antagonist	-0.1599	-0.4201	1	291	445	36	2010.5
1848	recombinant human tau	-0.9375	0.3977	4	174	244	14	2000.2143
1849	recombinant tau	-0.9102	0.3403	4	352	664	41	2002.878
1850	recommendation	0.7878	-0.2239	2	226	368	22	2010.0455
1851	reelin	-0.5061	-0.0495	1	101	131	12	2009.9167
1852	refinement	0.5075	-0.1862	2	192	283	14	2012.0714
1853	regional distribution	0.2048	0.4115	3	277	388	26	2005.7308
1854	registry	0.7881	0.2297	2	249	410	19	2009.7368
1855	regression analysis	1.2827	0.0324	2	318	598	30	2010.3
1856	regulation	-0.7628	-0.1866	1	1358	5515	431	2008.3643
1857	regulator	-0.7821	-0.1053	1	576	1160	88	2009.4545
1858	regulatory mechanism	-0.9111	-0.0558	4	222	317	21	2009.1905
1859	regulatory subunit	-0.9855	-0.0748	4	155	224	15	2005.6667
1860	related tauopathy	-0.8549	0.0636	4	344	663	50	2010.48
1861	reliability	0.7158	-0.21	2	321	534	31	2006.0323
1862	reliable biomarker	1.0475	-0.1978	2	184	291	15	2011.2667
1863	reliable marker	0.528	0.2142	3	190	265	15	2004.8667
1864	repeat	-0.7734	0.4286	4	721	2027	125	2004.232
1865	repeat domain	-0.941	0.2452	4	348	861	54	2006.6481
1866	repeat region	-0.9075	0.4141	4	222	387	24	1999.4167
1867	repeat tau	-0.3434	0.5161	3	348	606	34	2005.6765
1868	reproducibility	0.5381	-0.1138	2	157	201	12	2005.3333
1869	rescue	-0.4705	-0.372	1	277	391	31	2011.3871
1870	residue	-0.9288	0.1943	4	943	3411	219	2005.0137
1871	restoration	-0.5769	-0.3752	1	369	587	40	2010.425
1872	resveratrol	-0.5296	-0.422	1	104	132	12	2013.0833
1873	retinoic acid	-0.7813	-0.1677	1	134	176	11	2007.8182
1874	rho	0.7806	0.1088	2	137	169	10	2008.8
1875	ribbon	-0.6498	0.4592	4	157	255	17	2001.2353
1876	rigidity	0.324	0.4736	3	230	367	21	2008.0952
1877	rivastigmine	0.0137	-0.3977	1	261	455	25	2008.36
1878	roc	1.4356	-0.2616	2	145	226	10	2010
1879	rod	-0.5111	0.1562	3	173	246	17	2003.7059
1880	ros	-0.5868	-0.3183	1	228	339	29	2011.2759
1881	routine clinical practice	1.3431	-0.3378	2	156	251	11	2009.9091
1882	s396	-0.6986	-0.4384	1	128	164	11	2011.9091
1883	sad	-0.4847	-0.5272	1	249	389	33	2011.0606
1884	safety	0.1371	-0.3843	1	416	823	50	2010.78
1885	saitohin	0.6909	0.5753	3	79	136	11	2005.4545
1886	saline	-0.4078	-0.5175	1	301	456	28	2008.75
1887	samp8	-0.5281	-0.4381	1	114	147	16	2011.875
1888	sample	0.756	0.174	2	1469	7051	424	2008.3726
1889	sample size	1.1451	0.2324	2	315	715	30	2011.2
1890	sandwich elisa	1.2325	-0.3313	2	222	396	22	2004.8636
1891	sandwich enzyme	1.2301	0.2186	2	248	497	27	2004.037
1892	sappalpha	0.5646	-0.4622	2	240	377	22	2010.8182
1893	sappbeta	0.9284	-0.4623	2	176	317	17	2012.8235
1894	sarkosyl	-0.691	0.2366	4	109	135	11	2004.3636
1895	sarkosyl insoluble fraction	-0.4441	0.3772	3	140	175	12	2009
1896	sarkosyl insoluble tau	-0.3642	0.5195	3	218	319	20	2007.7
1897	scale	0.7433	-0.2566	2	662	1515	83	2008.2771
1898	scan	0.9853	0.1392	2	559	1224	57	2010.807
1899	sci	0.074	0.1222	4	279	452	23	2007.6522
1900	scjd	0.4744	0.3258	3	122	177	10	2012
1901	score	1.1131	0.0474	2	991	4749	244	2009.1557
1902	sds	-0.8132	0.4963	4	271	505	31	1995.9032
1903	sds page	-0.9274	0.4228	4	137	192	13	1999.3077
1904	secondary structure	-0.9068	0.276	4	151	223	16	2005.25
1905	secretase	-0.2603	-0.3096	1	843	1916	146	2010.2123
1906	secretase inhibitor	0.0661	-0.3913	1	336	552	38	2008
1907	section	-0.2718	0.4029	3	852	2226	165	2001.3152
1908	seed	-0.6611	0.1945	4	232	361	32	2012.3125
1909	selection	0.5075	-0.3037	2	497	929	55	2010.0545
1910	selective inhibitor	-0.6804	-0.3854	1	194	280	19	2006.0526
1911	selective vulnerability	-0.3178	0.2223	3	129	148	13	2007.3077
1912	self aggregation	-0.7888	0.1899	4	167	215	15	2008.5333
1913	self assemble	-1.0578	0.2957	4	130	281	17	2001.7647
1914	self assembly	-1.0448	0.219	4	285	638	38	2004.7368
1915	self association	-0.9388	0.2994	4	129	185	12	2002.9167
1916	semantic dementia	0.5469	0.504	3	279	631	34	2008.5882
1917	semantic memory	1.2035	0.1035	2	127	169	11	2009.4545
1918	senile plaque neurite	-0.6613	0.5773	4	127	221	14	1992.3571
1919	sensitivity	1.1263	-0.2861	2	1090	5664	285	2008.3544
1920	separation	1.0249	-0.2256	2	317	517	27	2005.963
1921	sequencing	0.0804	0.6073	3	367	608	39	2003.641
1922	sequestration	-1.0342	0.1793	4	307	507	31	2005.8387
1923	ser	-1.0673	0.0325	4	681	2160	130	2005.4692
1924	ser thr	-1.0253	0.0197	4	147	238	14	2007.5
1925	ser199	-1.0903	-0.1816	4	228	447	23	2006.4783
1926	ser202	-1.0945	-0.1585	4	345	716	35	2004.2857
1927	ser214	-1.112	-0.12	4	243	448	20	2004.95
1928	ser235	-1.1248	0.1283	4	229	382	18	2002.7778
1929	ser262	-1.0828	-0.0721	4	421	982	51	2006.4314
1930	ser396	-1.0485	-0.2074	4	472	1129	62	2007.4516
1931	ser396 ser404	-0.9967	-0.2818	1	144	213	12	2005.3333
1932	ser404	-1.1007	-0.1769	4	256	553	27	2005.3333
1933	ser9	-0.9332	-0.3999	1	187	322	19	2010
1934	serial section	-0.2508	0.4094	3	128	156	13	1999.4615
1935	serine	-0.9867	-0.0195	4	826	2509	157	2005.4459
1936	serum level	0.5674	-0.5563	2	179	252	19	2010.7895
1937	severe ad	0.5858	-0.194	2	205	288	18	2006.1111
1938	severe dementia	0.4632	0.0786	3	159	196	12	2009.5833
1939	severe neuronal loss	0.123	0.4545	3	124	162	12	2008.4167
1940	sex	1.086	0.2063	2	678	1863	98	2009
1941	sh sy5y	-0.8207	-0.2163	1	173	257	18	2008.1111
1942	sh sy5y cell	-0.7258	-0.2419	1	399	733	53	2009.8302
1943	sh sy5y neuroblastoma cell	-0.6576	-0.0958	1	223	307	20	2008.9
1944	sham	-0.4213	-0.5167	1	158	208	14	2008.5714
1945	sibling	0.2916	0.5404	3	171	234	14	2006.7857
1946	side effect	-0.0932	-0.3656	1	373	592	49	2010.2041
1947	signal transduction	-0.5245	-0.1737	1	237	343	33	2005.7879
1948	signal transduction pathway	-0.7716	-0.2808	1	186	297	23	2005
1949	signaling	-0.5427	-0.3166	1	806	1869	155	2010.7677
1950	significant association	0.9352	0.4164	2	407	865	56	2009.7857
1951	significant correlation	0.8749	-0.0172	2	574	1377	81	2006.4444
1952	significant difference	0.6643	0.0202	2	856	2419	145	2008.2552
1953	significant impairment	-0.3442	-0.4191	1	106	134	11	2011.5455
1954	significant improvement	-0.1894	-0.438	1	198	240	19	2010.7895
1955	significant inverse correlation	0.6823	-0.1192	2	116	151	11	2006.6364
1956	significant positive correlation	0.7621	-0.1675	2	199	289	19	2009.1579
1957	significant proportion	0.335	0.2267	3	117	144	10	2007.7
1958	silencing	-0.676	-0.3354	1	164	215	19	2012.2632
1959	silver	-0.243	0.4009	3	181	263	20	2004.5
1960	silver staining	-0.2452	0.3908	3	208	283	20	2003.75
1961	similar result	0.7839	-0.3329	2	351	536	30	2008.2
1962	single gene	-0.6374	0.2665	4	108	146	10	2002.9
1963	single nucleotide polymorphism	0.903	0.4671	2	371	1085	68	2010.9706
1964	single photon emission	0.7711	-0.0139	2	219	340	18	2009.3333
1965	sirna	-0.6915	-0.2593	1	113	145	13	2011.0769
1966	sirt1	-0.5377	-0.4107	1	83	103	10	2012.1
1967	sirtuin	-0.536	-0.4111	1	109	139	13	2011.6923
1968	site	-0.9394	0.0094	4	1499	8308	553	2005.1447
1969	situ	-0.9832	0.2507	4	154	195	14	2001.2857
1970	sleep	0.5699	-0.1927	2	153	198	15	2012.2667
1971	slice	-0.8946	-0.2499	1	263	436	34	2005.0588
1972	small amount	-0.6112	0.3281	4	156	183	13	2002.0769
1973	small molecule	-0.3336	-0.2507	1	247	335	29	2012.5517
1974	smi	-0.4426	0.4486	3	120	156	11	1997.1818
1975	snap	0.5548	0.1813	2	124	154	11	2008.3636
1976	snp	0.9219	0.4593	2	396	1222	73	2011.5753
1977	society	0.0162	-0.3449	1	227	329	33	2009.5152
1978	sod	-0.6426	-0.353	1	163	203	13	2008.3077
1979	sodium dodecyl sulfate	-0.8071	0.4968	4	127	175	11	1997.1818
1980	solanezumab	0.1116	-0.4146	1	135	200	13	2014
1981	solubility	-0.7115	0.0761	4	311	428	34	2007.5882
1982	soluble protein	-0.9047	0.2593	4	177	247	19	2006.2105
1983	soluble tau	-0.7401	0.3571	4	395	658	50	2005.24
1984	soma	-0.4092	0.3426	3	227	330	23	2006.8261
1985	somatodendritic compartment	-0.665	0.2202	4	231	315	25	2005.04
1986	somatostatin	-0.3185	0.426	3	125	177	15	2001
1987	sorl1	0.9755	0.4344	2	143	210	14	2012.7143
1988	spatial distribution	-0.6661	-0.0618	1	94	107	10	2003.7
1989	spatial learning	-0.4522	-0.4686	1	349	622	50	2012.06
1990	spatial memory	-0.3872	-0.442	1	328	509	43	2011.6744
1991	spatial memory deficit	-0.5051	-0.4656	1	164	225	19	2011.6842
1992	spatial memory impairment	-0.6028	-0.5023	1	133	185	12	2012.6667
1993	special attention	-0.1411	-0.4169	1	108	121	12	2009.75
1994	specific antibody	-0.6227	0.2336	4	572	1085	80	2005.2375
1995	specific biomarker	0.8017	-0.0378	2	255	417	23	2011.3478
1996	specific inhibitor	-0.8198	-0.2816	1	267	427	29	2007.0345
1997	specific marker	0.4772	0.045	2	329	502	30	2005.3
1998	specific monoclonal antibody	-0.6386	0.2906	4	178	236	18	2008.0556
1999	specific site	-0.9817	-0.2023	1	257	380	22	2006.8636
2000	specificity	1.0163	-0.2631	2	1277	6627	345	2007.542
2001	spect	0.8218	-0.0515	2	354	738	40	2007.675
2002	spectroscopy	-0.8751	0.28	4	465	925	64	2006.6094
2003	speed	0.6892	-0.0606	2	346	538	31	2010.4839
2004	spinal cord	-0.3968	0.2018	3	387	640	43	2005.9302
2005	spine	-0.4974	-0.1038	1	195	268	21	2010.9524
2006	splicing	-0.5155	0.2017	4	350	616	45	2008.8
2007	spongiosis	0.1423	0.491	3	158	220	13	2005.6154
2008	sporadic ad patient	0.6463	0.5538	3	114	141	11	2007.3636
2009	sporadic case	0.2552	0.4795	3	181	258	22	2006.0909
2010	sporadic creutzfeldt jakob disease	0.477	0.3241	3	119	189	12	2009.5833
2011	sporadic inclusion body myositis	-0.2436	0.1136	3	91	202	18	2002.1111
2012	sporadic tauopathy	-0.0309	0.6164	4	90	127	10	2007.1
2013	stabilization	-0.8026	0.0694	4	428	692	51	2008.2745
2014	stable mci	1.5067	-0.2337	2	217	496	22	2010.6364
2015	stain	-0.1332	0.4727	3	410	804	64	1999.8125
2016	staining	-0.3493	0.3468	3	931	2733	211	2002.5782
2017	standardization	1.1076	-0.3843	2	271	613	29	2011.1379
2018	statin	-0.0659	-0.4126	1	254	395	34	2006.6765
2019	statistical analysis	1.0126	0.1773	2	306	471	25	2008.4
2020	statistical significance	0.7593	0.4028	2	156	198	12	2009.0833
2021	status	0.9788	0.264	2	925	3015	174	2009.6782
2022	steady state level	-0.4219	-0.3789	1	128	163	12	2009.4167
2023	stem cell	-0.3532	-0.2956	1	256	367	36	2012.3611
2024	sth	0.6907	0.576	3	75	144	11	2004.7273
2025	straight filament	-0.9429	0.3547	4	390	983	57	1999.2807
2026	stratification	1.1431	0.2727	2	377	785	39	2010.5897
2027	streptozotocin	-0.4916	-0.555	1	257	564	38	2012.1053
2028	strong correlation	0.9796	-0.0142	2	184	263	13	2011.1538
2029	structural magnetic resonance imaging	1.3523	0.0701	2	198	377	16	2012.25
2030	structural mri	1.287	0.1049	2	200	347	15	2011.8
2031	structure activity relationship	-0.1418	-0.4107	1	117	142	13	2011.1538
2032	stz	-0.4883	-0.5576	1	223	461	29	2012.2759
2033	subcellular distribution	-0.5751	0.0853	1	116	153	12	2007.75
2034	subcellular localization	-0.6526	-0.0069	1	133	163	14	2007.6429
2035	subcortical area	0.3585	0.3757	3	149	166	11	2005
2036	subcortical nuclei	-0.161	0.4774	3	115	172	15	2000
2037	subcortical region	0.431	0.5458	3	140	160	10	2005.9
2038	subgroup	0.9175	0.165	2	774	2082	120	2008.375
2039	subiculum	-0.2648	0.3452	3	356	609	42	2003.6429
2040	subject	0.9217	0.0785	2	1532	10458	593	2008.8449
2041	subjective cognitive impairment	1.2791	-0.0379	2	194	372	17	2012.7647
2042	subjective memory complaint	1.3312	-0.0336	2	201	325	13	2010.0769
2043	subpopulation	-0.3736	0.2867	3	358	519	39	2003.0513
2044	substantia nigra	0.0229	0.4405	3	399	728	49	2006.0612
2045	subtype	0.444	0.3278	3	619	1158	75	2007.8
2046	subunit	-0.5448	0.1352	1	665	1370	102	2003.6863
2047	success	0.0889	-0.2804	1	353	533	43	2010.1163
2048	superoxide dismutase	-0.6613	-0.3546	1	275	405	27	2007.6296
2049	surgery	-0.1968	-0.5292	1	252	398	30	2012.0667
2050	surrogate marker	0.7426	-0.0586	2	222	336	19	2009.8421
2051	swe	-0.3708	-0.3697	1	228	355	28	2009.9643
2052	sweden	1.4227	-0.1355	2	236	406	16	2010.0625
2053	swedish mutation	-0.6047	-0.363	1	192	304	21	2008.6667
2054	symptom onset	0.8603	0.2081	2	241	407	18	2010.7778
2055	symptomatic relief	-0.0411	-0.3562	1	113	133	13	2010.2308
2056	symptomatic treatment	0.0891	-0.394	1	327	540	35	2007.3714
2057	synapsin	-0.6007	-0.1044	1	103	133	11	2011
2058	synaptic deficit	-0.4918	-0.2829	1	174	208	20	2012.7
2059	synaptic density	-0.3922	-0.2302	1	120	134	11	2009.5455
2060	synaptic failure	-0.4032	-0.1998	1	131	158	15	2010.4
2061	synaptic function	-0.4774	-0.3221	1	434	690	60	2011.6167
2062	synaptic impairment	-0.5231	-0.2741	1	117	148	13	2013.3077
2063	synaptic plasticity	-0.4997	-0.2904	1	645	1303	118	2010.6695
2064	synaptic transmission	-0.504	-0.2774	1	295	441	39	2011.1026
2065	synaptogenesis	-0.3338	-0.2902	1	98	120	10	2008.4
2066	synaptotoxicity	-0.4757	-0.261	1	131	158	15	2011.7333
2067	synthetic peptide	-0.8715	0.4699	4	305	602	37	1997.3243
2068	synucleinopathy	0.3577	0.4035	3	303	557	37	2010.7568
2069	systematic review	1.085	-0.246	2	124	181	11	2011.8182
2070	systemic inflammation	-0.3094	-0.4159	1	107	119	12	2014
2071	t allele	0.8975	0.4789	2	102	165	12	2007.9167
2072	t tau	1.3958	-0.1627	2	745	3713	166	2011.6084
2073	t2d	-0.432	-0.5814	1	100	161	11	2013.8182
2074	t2dm	-0.4535	-0.5668	1	239	386	27	2012.1111
2075	tacrine	0.0164	-0.4005	1	152	206	12	2005.1667
2076	tangle bearing neuron	-0.4812	0.3314	3	276	405	28	2003.1071
2077	tar dna binding protein	0.3849	0.5234	3	213	324	19	2010.7895
2078	tau abnormality	-0.2256	0.2378	3	149	181	15	2006.2
2079	tau aggregate	-0.5976	0.1457	4	527	964	77	2009.9481
2080	tau aggregation	-0.7888	0.1216	4	604	1173	92	2009.7826
2081	tau antibody	-0.6465	0.4909	4	461	834	51	2003.0588
2082	tau clearance	-0.7074	-0.0372	4	139	192	15	2013.0667
2083	tau concentration	0.8725	-0.1987	2	361	638	38	2007.4474
2084	tau dephosphorylation	-1.0477	-0.2327	4	134	238	13	2009.1538
2085	tau deposit	-0.2128	0.4218	3	340	577	38	2007.0526
2086	tau dysfunction	-0.5184	0.2987	4	181	294	21	2007.0476
2087	tau epitope	-0.7136	0.4568	4	424	816	50	2000.3
2088	tau expression	-0.563	-0.0957	1	381	553	47	2011.0851
2089	tau fibril	-0.6843	0.195	4	218	360	30	2011.0667
2090	tau fibrillization	-0.8045	0.2279	4	115	162	12	2009.0833
2091	tau filament	-0.7855	0.2787	4	427	847	54	2005.5
2092	tau fragment	-0.8564	0.2811	4	353	666	50	2005.52
2093	tau function	-0.8412	0.0592	4	175	235	22	2008.2727
2094	tau gene	0.1225	0.5641	3	573	1395	92	2004.6413
2095	tau hyperphosphorylation	-0.697	-0.4041	1	1116	3934	286	2009.2552
2096	tau immunoreactivity	-0.4289	0.4377	3	406	712	55	1999.8727
2097	tau immunotherapy	-0.3298	-0.1326	1	93	123	11	2013.3636
2098	tau inclusion	-0.4945	0.341	4	361	583	40	2008.825
2099	tau isoform	-0.8262	0.4193	4	570	1428	90	2001.4222
2100	tau kinase	-0.8936	-0.2719	1	600	1478	96	2008.7708
2101	tau level	0.7275	-0.2861	2	819	2295	133	2007.8947
2102	tau modification	-0.7058	0.1476	4	248	352	24	2007.7917
2103	tau molecule	-0.8884	0.4352	4	362	829	55	1999.4545
2104	tau monomer	-0.8474	0.2495	4	135	224	15	2007.5333
2105	tau mutation	-0.0583	0.4955	3	371	674	43	2004.9302
2106	tau neuropathology	-0.3508	-0.4109	1	107	123	10	2011.9
2107	tau oligomer	-0.7308	0.1355	4	349	584	47	2012.2128
2108	tau peptide	-0.8951	0.3314	4	299	492	34	2004.9412
2109	tau phosphorylation	-0.8061	-0.2675	1	1361	6741	491	2008.3951
2110	tau phosphorylation site	-1.0575	-0.0208	4	166	244	14	2006.6429
2111	tau polymerization	-0.9123	0.2421	4	142	221	16	2004.75
2112	tau positive neurofibrillary tangle	-0.2128	0.4578	3	167	205	16	2004.25
2113	tau positive neuron	-0.2903	0.3908	3	129	180	14	2004.3571
2114	tau protein deposit	-0.0558	0.2699	3	166	202	13	2008.4615
2115	tau protein hyperphosphorylation	-0.5985	-0.4279	1	170	260	22	2009.4091
2116	tau protein kinase	-1.0739	-0.0475	4	236	422	26	2002.5
2117	tau protein level	0.8598	-0.0897	2	370	663	44	2006.9773
2118	tau ratio	1.3423	-0.1114	2	322	663	29	2010.7931
2119	tau toxicity	-0.6473	-0.1295	1	128	184	16	2011.5
2120	tau transgenic mouse	-0.613	-0.0814	1	437	738	53	2010.566
2121	tauopathies	-0.6774	0.1319	4	280	431	31	2011.6452
2122	tauopathy mouse model	-0.6817	0.183	4	105	129	12	2012.5
2123	tdp	0.3388	0.4855	3	539	1319	85	2011.4588
2124	technology	0.4508	-0.3062	2	601	1250	84	2010.0357
2125	tem	-0.8876	0.3507	4	81	128	11	2002.1818
2126	temporal cortice	0.1964	0.3878	3	219	312	21	2004.4286
2127	temporal lobe	0.1845	0.4592	3	586	1075	68	2005.6029
2128	temporal neocortex	0.0209	0.4236	3	215	281	17	2003.7647
2129	test	0.6151	-0.2208	2	1250	4757	289	2009.0588
2130	tg mouse	-0.441	-0.3435	1	370	578	52	2009.4038
2131	tg2576	-0.589	-0.3663	1	153	200	16	2009.0625
2132	thalamus	0.1328	0.4852	3	192	242	16	2005.625
2133	therapeutic benefit	-0.0956	-0.3887	1	171	207	18	2011.7778
2134	therapeutic effect	-0.3675	-0.4934	1	393	629	46	2012.913
2135	therapeutic efficacy	-0.3677	-0.4489	1	176	218	17	2010.8235
2136	therapeutic potential	-0.4241	-0.4332	1	402	611	55	2010.3091
2137	thioflavin s	-0.4756	0.384	3	167	215	16	2004.3125
2138	thioflavine s	-0.3265	0.4318	3	137	191	15	1997.1333
2139	thr	-1.041	-0.0543	4	456	1033	60	2007.1333
2140	thr181	-1.0665	-0.1671	4	218	321	17	2008.2941
2141	thr212	-1.09	-0.1273	4	195	328	15	2007.4667
2142	thr231	-1.0673	-0.1192	4	386	763	39	2007.3846
2143	thread	-0.0983	0.4897	3	256	388	27	2001.2963
2144	tissue section	-0.5934	0.5405	4	379	727	51	1999.7255
2145	tnfalpha	-0.4889	-0.4813	1	127	159	12	2009.25
2146	tolerability	0.3027	-0.5177	1	177	332	17	2010.6471
2147	tomography	0.7929	-0.0123	2	344	644	34	2008.5294
2148	total	1.0572	-0.108	2	870	2489	127	2009.378
2149	total tau	1.2051	-0.2223	2	1211	8752	446	2010.6076
2150	total tau level	0.5169	-0.138	2	429	701	39	2010.3077
2151	total tau protein	1.2755	-0.3157	2	478	1370	71	2008.9296
2152	toxic function	-0.562	0.3262	4	123	160	12	2008
2153	toxic gain	-0.7276	0.0868	4	142	181	15	2008.5333
2154	toxic species	-0.6272	0.0471	4	163	207	23	2011.3913
2155	toxin	-0.7085	-0.3528	1	175	232	19	2010.0526
2156	tracer	0.7425	0.0668	2	277	471	28	2013.0357
2157	training	0.1412	-0.5151	1	149	198	14	2011.4286
2158	tran	-0.9953	0.0025	4	292	558	37	2009.7297
2159	transcription factor	-0.6403	-0.2314	1	355	525	41	2009.6829
2160	transfected cell	-0.8787	0.0348	4	142	187	13	2003.4615
2161	transfection	-0.9479	-0.1042	4	251	383	22	2005.8636
2162	transgene	-0.3821	-0.3409	1	406	685	61	2009.6066
2163	transgene expression	-0.3606	-0.1623	1	124	158	14	2009.4286
2164	transgenic ad mouse	-0.3236	-0.398	1	182	235	18	2012.5
2165	transgenic line	-0.3992	-0.3254	1	99	122	13	2007.6154
2166	transgenic mouse line	-0.3935	-0.3248	1	131	173	19	2006.4211
2167	transglutaminase	-0.6115	0.3647	4	162	227	20	2003.2
2168	translocation	-0.7253	-0.156	1	303	505	33	2008.7576
2169	transmission electron microscopy	-0.8668	0.3315	4	232	406	27	2004.5926
2170	treatment effect	0.7065	-0.4523	2	267	458	22	2010.8636
2171	treatment option	-0.0502	-0.4004	1	210	266	24	2011.3333
2172	tremor	0.3269	0.4662	3	150	196	15	2008.1333
2173	trial	0.3176	-0.3967	1	968	3092	195	2010.6051
2174	trial registration	0.653	-0.5355	2	139	244	10	2012.9
2175	triple transgenic	-0.3709	-0.3987	1	227	347	27	2011.5556
2176	triple transgenic ad mouse	-0.3628	-0.4035	1	121	154	14	2011.4286
2177	triple transgenic alzheimer	-0.3564	-0.4121	1	168	246	19	2012.2105
2178	triple transgenic model	-0.357	-0.3703	1	84	104	11	2010.5455
2179	triple transgenic mouse	-0.3695	-0.391	1	293	497	40	2011.45
2180	triple transgenic mouse model	-0.365	-0.3875	1	324	578	54	2011.1296
2181	truncated form	-0.8824	0.1181	4	160	200	15	2009
2182	truncated tau	-0.6219	0.1982	4	237	353	29	2007.5862
2183	truncation	-0.8082	0.1895	4	410	836	60	2009.3333
2184	tubulin	-1.0075	0.194	4	545	1438	91	2001.956
2185	tumor necrosis factor alpha	-0.2807	-0.4044	1	255	343	27	2009.6667
2186	tunel	-0.4128	-0.0749	1	216	326	21	2006.4286
2187	typical ad	0.566	0.3055	3	131	176	11	2010.9091
2188	tyr	-0.9207	0.1482	4	179	235	13	2007.2308
2189	tyrosine	-0.853	0.1104	4	314	571	37	2007.4054
2190	tyrosine phosphorylation	-0.8269	0.069	4	194	306	20	2007.95
2191	ubiquitin	-0.2824	0.4717	3	886	2706	195	2001.0513
2192	ubiquitin immunoreactivity	-0.4191	0.525	3	185	272	19	1996.4211
2193	ubiquitin positive inclusion	0.2872	0.5002	3	156	234	14	2007.2857
2194	ubiquitination	-0.8253	0.1713	4	251	422	33	2005.1515
2195	ultrastructural study	-0.1174	0.5011	3	113	132	11	2002.7273
2196	ultrastructure	-0.4383	0.5082	3	186	316	24	2002.2083
2197	uncertainty	0.4831	-0.2595	2	167	224	14	2008.6429
2198	underlying molecular mechanism	-0.5066	-0.3675	1	124	139	12	2011.4167
2199	unfolded protein	-0.9276	0.2191	4	171	245	14	2008.4286
2200	unfolded protein response	-0.7138	-0.2522	1	178	322	24	2011.5417
2201	united state	0.9423	-0.049	2	162	227	13	2009.1538
2202	university	1.2339	0.058	2	245	449	22	2010.4091
2203	unknown mechanism	-0.3256	0.0263	1	203	246	15	2005.0667
2204	upr	-0.7162	-0.255	1	128	227	15	2011.3333
2205	upregulation	-0.5788	-0.3432	1	501	875	71	2011.1831
2206	urgent need	0.8274	-0.3407	2	186	266	19	2012.0526
2207	urine	0.7339	-0.1913	2	134	191	11	2007
2208	useful biomarker	0.9919	-0.2329	2	197	307	18	2006.7778
2209	useful marker	1.0451	-0.3643	2	140	213	13	2006
2210	usefulness	1.0361	-0.133	2	444	916	51	2007.2745
2211	utility	0.9066	-0.1341	2	693	1582	89	2009.764
2212	vaccination	-0.019	-0.3572	1	295	499	43	2009.2791
2213	vaccine	-0.0078	-0.3707	1	315	622	57	2011.1228
2214	vad	0.8933	-0.0982	2	359	842	48	2007.2083
2215	validation	0.855	-0.2467	2	549	1219	68	2011.4265
2216	validity	0.5432	-0.3055	2	344	582	37	2010.9459
2217	value	0.9697	-0.2112	2	1220	5851	315	2009.1937
2218	variability	0.8888	0.2631	2	644	1635	92	2009.337
2219	variable	1.1844	0.056	2	632	1919	89	2009.764
2220	variance	1.0772	0.2351	2	345	609	33	2009.5152
2221	variation	0.7416	0.3298	2	784	1943	122	2008.082
2222	vascular dementia	0.8057	-0.1334	2	793	2588	154	2006.5974
2223	vascular disease	0.631	-0.0996	2	219	340	24	2009.2917
2224	vascular endothelial growth factor	0.6607	-0.123	2	178	236	15	2012
2225	vascular lesion	0.7031	0.263	3	191	254	19	2008.1053
2226	vascular risk factor	0.6353	-0.1261	2	270	426	33	2010.0606
2227	vector	-0.3724	-0.2498	1	289	396	34	2011.2059
2228	vegf	0.6603	-0.125	2	179	236	15	2011.3333
2229	vehicle	-0.462	-0.4897	1	330	535	40	2010.325
2230	viability	-0.6836	-0.2007	1	354	506	34	2007.7647
2231	vicinity	-0.4503	0.1825	3	209	266	21	2003.9048
2232	vicious cycle	-0.5545	-0.3362	1	139	173	18	2009.3333
2233	vilip	1.3442	-0.0188	2	157	254	10	2012.5
2234	vitamin e	-0.0105	-0.4294	1	171	241	16	2005.5625
2235	vitro	-0.8118	-0.0234	4	1438	6545	466	2006.5043
2236	vitro experiment	-0.526	-0.1918	1	103	114	10	2008.1
2237	vitro model	-0.7228	-0.2096	1	253	360	32	2009.3438
2238	vitro phosphorylation	-1.0878	0.1968	4	138	186	12	2002.6667
2239	vivo detection	0.5003	-0.0023	2	130	184	13	2010.7692
2240	vivo diagnosis	0.8511	0.1507	2	128	175	10	2011
2241	vivo model	-0.6576	-0.2643	1	275	370	27	2008.5926
2242	volume	1.1038	0.1331	2	705	2192	110	2010.7545
2243	voxel	1.0491	0.2132	2	415	997	44	2011
2244	wall	-0.1318	0.3821	3	255	402	36	2001.5
2245	western blotting	-0.5392	-0.0124	1	567	1045	77	2008.3377
2246	white matter	0.1287	0.4671	3	677	1453	96	2003.9271
2247	white matter change	0.8813	0.17	2	143	195	12	2008.8333
2248	white matter hyperintensity	1.3335	0.1097	2	160	271	13	2012.3846
2249	white matter lesion	0.9909	0.1074	2	201	314	18	2008.5556
2250	whole brain	0.6062	0.478	3	162	206	13	2009.5385
2251	wide association study	0.9519	0.4209	2	194	350	21	2013.2381
2252	wild type	-0.5152	-0.2448	1	779	1675	131	2010.3053
2253	wild type mouse	-0.4141	-0.3157	1	406	634	57	2011.614
2254	wild type tau	-0.9133	0.096	4	199	330	20	2007.55
2255	wnt	-0.7573	-0.3577	1	144	217	16	2008.1875
2256	woman	0.5936	0.0926	2	579	1118	65	2007.2
2257	word	-0.5102	0.554	4	337	539	30	1995.3667
2258	world	0.2778	-0.1972	1	340	575	42	2009.1905
2259	wortmannin	-0.992	-0.3837	1	103	204	12	2003.3333
2260	wt mouse	-0.3546	-0.4718	1	164	220	18	2012.3889
2261	x tg ad mouse	-0.3488	-0.3973	1	95	107	11	2011.8182
2262	y maze	-0.4092	-0.4455	1	116	148	12	2010.75
2263	year	0.6345	0.0582	2	1737	12690	825	2008.7297
2264	year old man	0.1807	0.4902	3	153	216	14	2003.7857
2265	year old woman	0.2402	0.492	3	134	164	12	2004.5833
2266	yeast	-0.7887	-0.0131	4	150	184	13	2010.3846
2267	ykl	1.3593	-0.0401	2	152	259	11	2013.4545
2268	young age	-0.392	-0.3048	1	121	134	11	2012.2727
